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Abstract
Protein/peptide characterization using mass spectrometry and molecular
dynamics simulations

Ahmad Kiani Karanji

Mass spectrometry (MS) based-techniques and molecular dynamics (MD) simulations have
been used to characterize protein/peptide structure as well as their interactions with lipid
vesicles and detergents. Chapter 1 introduces an introduction to the concepts and tools that
were used in this work. In Chapter 2, the dominant gas-phase conformer of [M+3H] 3+ ions of the
model

peptide

Acetyl-PSSSSKSSSSKSSSSKSSSSK

are

examined

with

ion

mobility

spectrometry (IMS), gas-phase hydrogen deuterium exchange (HDX), and mass spectrometry
(MS) techniques. This section furthers the development of a protein structural prediction tool by
providing information about gas-phase ion conformers of two model peptides having different
solution conformational states. In Chapter 3, interactions between the first 17 amino acid
residues (Nt17 peptide) of the Huntingtin protein (htt) with lipid vesicles comprised of two
subclasses of phospholipids are examined using electrospray ionization - mass spectrometry
(ESI-MS) and MD simulations. Notably, the aggregation of Htt results in Huntington’s disease
(HD). Chapter 4 presents a MD simulations study of proteorhodopsin (PR) oligomers in different
membrane environments. Proteorhodopsins are transmembrane proteins and members of the
microbial rhodopsin family which act as a proton pump in the bioenergetics processes in
bacteria. Finally, Chapter 5 discusses future directions for utilizing experimental and
computational methods to obtain information about protein/peptide structure.

Overall, the

combination of MS-based techniques and MD simulations is shown to provide unique and
enhanced structural information for intractable protein/peptide species.
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1. Introduction: Tools Used for protein/peptide structure
characterization
and
identification
of
protein-lipid
interactions: Electron Transfer Dissociation (CID), Ion
Mobility
Spectrometry-Mass
Spectrometry
(IMS-MS),
Molecular Dynamics (MD) Simulations, and Hydrogen
Deuterium Exchange
Protein/peptide characterization
Proteins are biopolymers containing sequences of amino acids bound together by
peptide bonds. These large biomolecules are involved in many biological activities such as
energy conversions, and chemical transportation

1-3

. The 3D structural characterization of

proteins is an important pre-requisite for studying the function of these large biomolecules in
biological media

4-5

. An error in the protein structure may lead to disease; for example;

misfolding of Huntingtin protein (htt) can lead to aggregation and the formation of amyloid fibrils
in neurons 6.
Historically, protein characterization has been conducted with spectroscopic methods
such as nuclear magnetic resonance (NMR)
12, 19-20

, UV-based methods

21-22

7-14

, fluorescence

and Raman spectroscopy

15-18

and circular dichroism (CD)

23

Along with these powerful

.

analytical techniques high resolution methods such as x-ray crystallography
electron microscopy

27-30

24-26

and cryo-

can be used to study protein structure and their interactions. Although

these traditional techniques are widely used, they suffer from some limitations such as
difficulties in sample preparation
some of the proteins

31

. It is worth mentioning that there is a limitation in crystalizing

32

. In addition, many of the membrane proteins are not soluble in water

because of their hydrophobic nature; therefore it can be difficult to study such structures using
NMR 9. Furthermore, some globular proteins tend to aggregate and create big systems which
are difficult to study using NMR (~15 KDa limitation)

31

. Another limitation can be that some of

1

the protein interactions are transient and cannot be captured using these traditional techniques
33

. Finally, it should be noted that an increasing number of studies is beginning to show the

presence of multiple, coexisting structures under native conditions

34-36

. Some of these

limitations can be addressed with mass spectrometry (MS) and mass spectrometry-based
techniques such as hydrogen deuterium exchange (HDX). Several advantages include those
associated with analysis speed and sensitivity as well as an ability to “freeze out” coexisting
structures 37-40.
Early MS-based studies of proteins involved studies of the conformational properties and
the folding pathways of native-like proteins using electrospray ionization-mass spectrometry
(ESI-MS)

41-45

. These studies were often performed to obtain information about the mechanism

of action of these important biomolecules. Shortly later, gas-phase separation techniques were
introduced as a tool to characterize protein structure

46-49

. In the gas phase, protein ion structure

is not stabilized through hydrogen bonding with the solvent molecules

46, 50-51

. Ion mobility

spectrometry-mass spectrometry (IMS-MS) was introduced to effectively increase the resolution
of the MS data and reveal different gas-phase structures corresponding to co-existing protein
conformations in solution

48, 52

. For

gas-phase ion structure characterization, IMS is an

appropriate separation technique because of its high compatibility with mass spectrometry
measurements

53-56

. Indeed, IMS-MS measurements were used early on to suggest that many

protein ions could remain in their solution conformational state for hundreds of milliseconds
which is sufficiently long enough to study with ion mobility instruments

57-59

. Other aspects of

MS-based studies include the theoretical investigations of the ionization processes of protein

60-

61

, and labeling techniques 31, 37, 62-63.
The combination of experimental techniques such as MS with molecular dynamics (MD)

simulations can provide valuable information regarding protein structures as well as their

2

interactions with other chemical species

64-67

. For example, MS can be used to provide

information about the contact sites of a protein interacting with other proteins or with other
biological compounds, as well as finding the structured/unstructured and rigid/dynamic regions
of a protein followed by relating this information to the higher-order structure

31

. The atomistic

view of MD simulations enables scientists to have a better understanding of the chemistry of
these molecules.

IMS-MS
Ion mobility spectrometry (IMS) is a gas-phase ion separation technique that has
frequently been used to study the structure of biomolecular ions

49

. The high compatibility of this

separation technique with MS makes it available in many newly designed commercial
instrumentations

68-69

. In this technique the separation is realized according to the ion’s charge

and overall size. IMS instrumentation consists of a drift tube (a pressurized enclosure) with
electrostatic lenses (Figure 1.1)

70

. The first step in an IMS measurement scheme is to ionize

the molecules thereby transferring the solution-phase molecules to the gas phase as ions. To
detect the molecules using a mass analyzer requires that the molecules are charged. Therefore,
an ionization technique to be used in such experiments should provide these two requirements
(volatilization and ionization)

60

. The ions originating from the source are then introduced to a

drift tube such as that shown in Figure 1.1 and subsequently separated according to their sizeto-charge ratios. The drift tube can be coupled with different mass analyzers such as the LTQ
mass spectrometer for mass analysis and ion detection

71

.

3

Figure 1. 1 Schematic diagram of an IMS-MS instrument used in the study of protein and
peptide ion structures. Shown is the electrospray ionization source, the source desolvation
region, the ion funnel (F1), ion activation (IA), and ion gate (G) regions. Also shown are the drift
tube lenses. Finally, the linear ion trap mass spectrometer is also shown. Figure adapted with
permission from 70.
An ion’s transit time inside the drift tube is referred to as the drift time (tD). This tD value
can be used to calculate the collision cross-section (CCS) of the ion

72

. The CCS can be loosely

described as the projection of the orientationally-averaged ion or the average area swept
through the buffer gas. CCS values can be calculated using the equation below.
Ω=

(

) /
(

) /

[

+

]

/
.

Equation 1. 1

In Equation 1.1, kB is the Boltzmann’s constant, T is the buffer gas temperature, the term [

+

] is the reduced mass, E is the electric field, and L is the length of the drift tube.

Hydrogen Deuterium Exchange (HDX)
One of the commonly used MS-based techniques in the study of protein structure is that
of hydrogen deuterium exchange (HDX). Traditionally performed in solution, HDX is based on
the replacement of accessible amide hydrogens with deuteriums along the protein backbone
73-74

.

1,

Areas in which exchange does not occur can then be ascertained using MS

measurements and such areas can be suggested to be involved in important interactions such
as the hydrogen bonding networks associated with secondary structural elements (a helices and
b sheets)

63, 75-79

. HDX experiments are possible because accessible protons on the protein are
4

constantly exchanging with the solvent protons; this process is not detectable by MS because
no mass change occurs 1. To carry out HDX experiments the sample is reacted with a
deuterated solvent such as D2O. Depending on the structure of the protein, some of the
backbone amide hydrogens will exchange with deuteriums. The HDX reaction can be quenched
after a certain period of time by lowering the pH and temperature

80

. Factors that affect the

amount of deuterium incorporation include the solution temperature and pH and the tertiary
structure of the protein

81

. Lowering the pH to a point (~3.0)

80

will result in decreased HDX

rates. Thereafter, HDX rates increase and deuterium incorporation is increased. Complete HDX
can happen on the ms time scale for random coil portions of proteins, but it will take minutes to
hours for the parts of the protein involved in establishing secondary structure. Therefore,
protection information can be correlated to higher order structure of proteins

81

.

Different methods can be utilized to detect the incorporated deuteriums in the protein
structure. One approach is to digest the protein to obtain smaller peptides using an enzyme in
the solution phase.

This is followed by cold liquid chromatography (LC) to separate the

peptides and detect them using subsequent mass analysis

82-85

. Another approach is to utilize

the intact protein ions and fragment them in the gas phase to determine where the deuteriums
were incorporated. In either case, the gas-phase dissociation technique to be used should be
non-ergodic in order to avoid the mobilization and scrambling of the deuterium label

86-88

.

More recently, gas-phase HDX has been introduced as a means to elucidate
protein/peptide ion structure

62-63, 89-91.

Here, the gas-phase protein ions are subjected

to collisions with a deuterating reagent gas (typically ND3 and D2O). As with solutionphase experiments, reaction occurs for accessible hydrogens. A notable difference is
that accessible hydrogens are those that are not buried (accessible to collisions) or are
accessible to original incorporation sites

1, 75, 78.

Therefore, the determination of
5

incorporation site is directly related to structural features such as surface accessibility
as well as accessibility to charge sites.

These features have been successfully

modeled to provide an estimation of the overall ion structure

92-93.

Electron Transfer Dissociation (ETD)
As mentioned above, HDX is a powerful method to study the structures of biomolecules.
Additionally, HDX can be performed in the solution phase using liquid chromatography-mass
spectrometry (LC-MS)
spectrometry

94

and online HDX

95

, or in the gas phase using drift tube ion mobility

96

[more refs including Clemmer]. There are two main methods of protein

characterization in the fields of structural and comparative proteomics. Introducing the peptides
resulting from enzymatic cleavage in the solution phase to the mass spectrometer is known as
the bottom-up approach

79-80

. Conversely, transferring the intact protein into the mass

spectrometer and using an appropriate gas-phase dissociation method is known as the topdown approach87-88. The former approach is the most commonly used method to detect
deuterium exchange in proteins, but it suffers from some limitations. One of the limitations for
bottom-up HDX is the deuterium back exchange with hydrogens

97

. This can occur to some

extent during the separation step and for this reason the HPLC separation is maintained at cold
temperatures.

Additionally, it can occur in the gas phase before the de-solvated ions are

analyzed by the mass spectrometer. Another limitation can be the lack of complete sequence
coverage using a bottom-up approach for some proteins

98-99

. To overcome these limitations, the

top-down approach can be utilized to determine the sites of deuterium incorporation. Top-down
proteomics can result in a per-residue level of resolution

100

. That said, there are only few

dissociation methods that can be used effectively in the top-down approach. The main problem
with conventional gas-phase fragmentation methods like collision-Induced dissociation (CID)
and higher-energy collisional dissociation (HCD) is that these methods elevate the internal

6

energy of the biomolecular ions 1. This excess amount of energy increases the mobilization of
exchangeable hydrogens which cases the protons (and deuterons) to move across the peptide
backbone and to other heteroatom sites. In the case of HDX this will randomize the distribution
of deuterium across the biomolecule. This process is called HDX scrambling

94

. Strategies to

overcome this problem are to use faster fragmentation techniques such as electron transfer
dissociation (ETD)

101-103

. Here, fragmentation happens after the molecule reacts with the ETD

reagent ions (typically radical anions). For ETD, a highly-charged ion (triply charged or
quadropoly charged) is often required.

MD Simulations
Molecular dynamics (MD) simulations is based on Newton’s second law

104

. Basically, it

is possible to calculate the position of the system at t+Δt and write a trajectory for the system
using Newton’s second law of motion (Equation 1.3) when the acceleration of the system, the
initial position at time t, and the position at time t-Δt are available as demonstrated in Equation
1.2 and 1.3.
𝑟(𝑡 + 𝛿𝑡) ≈ 2𝑟(𝑡) − 𝑟(𝑡 − 𝛿𝑡) + 𝑎(𝑡)𝛿𝑡
𝑚

⃗

= 𝐹⃗ = −∇⃗𝑈(𝑅⃗ )

Equation 1. 2
Equation 1. 3

In these equations, 𝑚 is the mass, and 𝑟⃗ is the position for each atom and 𝐹⃗ is the applied
force on that atom. Also 𝑈 𝑅⃗ is the potential energy which is defined as:
𝑈(𝑟⃗ , 𝑟⃗ , 𝑟⃗ , … 𝑟⃗ ) = 𝑈(𝑅⃗ )

Equation 1. 4

To write a trajectory it is essential to calculate the acceleration of an atom. Using
equation 1.3 the acceleration (a) of each atom can be calculated. In order to calculate 𝑎, a
knowledge of the forces exerted upon it is required. And finally, to acquire the forces, it is
necessary to define energy functions 𝑈(𝑟⃗ ) for each particle. These energy functions are the
sum of bonded and nonbonded terms. The bonded terms are usually defined for bonds
7

(Equation 1.5), angles, dihedrals angles, and improper angles (Equation 1.6). Non-bonded
interactions consist of Lenard-Jones potentials and charge-charge potentials (Equation 1.7).
𝑈(𝑅⃗ ) = 𝑈

+ 𝑈

𝑈

+ 𝑈

= 𝑈

𝑈

𝑈

= ∑𝑘

𝑈

= ∑𝑘

in which 𝑘

+ 𝑈

= 𝑈

For each of the 𝑈

𝑈

Equation 1. 5
Equation 1. 6

+𝑈

Equation 1. 7

+ 𝑈

terms the definition is:
Equation 1. 8,

(𝑟 − 𝑟 )

Equation 1. 9, and

(𝜃 − 𝜃 )

= ∑𝑘

Equation 1. 10,

[1 + cos(𝑛 ∅ + 𝛿 )]

is the bond energy constant, 𝑟 is the distance between any pair of atoms, 𝑟 is

the equilibrium distance between any pair of atoms, 𝑘

is the angular energy constant , 𝜃 is

the angle between three atoms bond together, 𝜃 is the equilibrium angle between three atoms
bond together, 𝑘

dihedral energy constant, 𝑛 is multiplicity, ∅ is the dihedral angle

between 4 atoms, and 𝛿 is the angle where the potential passes through its minimum value.
For the 𝑈

terms the definition is:

𝑈

= ∑

∑

𝑈

= ∑

∑

4𝜀 [(

)

−(

Equation 1. 11, and

) ]

Equation 1. 12,

in which 𝜀 is the depth of the potential well, 𝜎 is the finite distance at which the inter-atomic
potential is zero, 𝑟 is the distance between two atoms, 𝑞 and 𝑞 are atomic charges, and 𝜀 is
Coulomb’s constant.
One of the applications of MD simulations in the field of mass spectrometry is to study
the behavior of molecules during the final stages of the ESI process

60

. An advantage of this

application arises because of the time scale over which the MD simulations can now be
8

performed as well as the fact that they provide an atomistic view that cannot be obtained in any
other fashion. This is the subject of Chapter 5 in this report.

Area per lipid
One of the concepts that is widely used in this document is the change of lipid
composition along with the tracking of the interaction of peptides with such membrane systems.
The lipid composition in eukaryotic membranes consists primarily of phosphatidylcholine (PC)
105

. This lipid type occupies more than 50% of the phospholipids in almost all eukaryotic

membranes. In an aqueous environment, phosphatidylcholine self-organizes spontaneously and
creates a lipid bilayer in which the polar headgroups face the polar solution and the nonpolar
tails face each other. Some of the PC lipids are saturated and therefore their tails are straighter.
A saturated PC has a low area-per-lipid value because of this ordered structure (Figure 2).
DMPC is one of the PC lipids that has a low area-per-lipid value because of the completely
saturated tail. Most PC lipids have one or two cis-unsaturated fatty acyl chain(s). This causes an
increase in the area-per-lipid value for the bilayer. Another way to increase the area-per-lipid
value is to introduce methyl groups in the tail such as 1,2-di-O-phytanyl-sn-glycero-3phosphocholine (PhPC). Figure 2 summarizes the area per lipid phenomenon.

DMPC

DOPC

PhPC

9

Figure 1. 2 Area per lipid Phenomenon. Shown are the lipid structures (left) for DMPC,
DOPC, and PhPC. The bilayer formed by each lipid system is illustrated in front of each
lipid. The area-per-lipid values for DMPC, DOPC and PhPC are 59.0 Å2 [93], 67.4 Å2 [94],
and 80.6 Å2 [20] respectively at 30 °C.

Structure Studies
In Chapter 2 a comparison between two synthetic peptides that differ significantly in
their native structure in the solution phase is performed using IMS, HDX, and MD
simulations. For a serine containing peptide (Acetyl-PSSSSKSSSSKSSSSKSSSSK), the
[M+3H]3+ ions are observed predominantly as a relatively compact conformer type. Upon
subjecting these ions to electron transfer dissociation (ETD), the level of protection for each
amino acid residue in the peptide sequence has been assessed. The overall per-residue
deuterium uptake is observed to be relatively more efficient for the neutral residues than for
the model peptide Acetyl-PAAAAKAAAAKAAAAKAAAAK. In comparison, the N-terminal
and C-terminal regions of the serine peptide show greater relative protection compared
with interior residues. Molecular dynamics (MD) simulations are used to generate
candidate structures for collision cross section and HDX reactivity matching. Hydrogen
accessibility scoring (HAS) for select structural candidates from MD simulations is used to
suggest conformer types that could contribute to the observed HDX patterns. The results
are discussed with respect to recent studies employing extensive MD simulations of gasphase structure establishment of a peptide system.
In Chapter 3 of this report, the interactions of the first 17 amino acid residues (Nt17
peptide) of the Huntingtin protein (htt) with lipid vesicles is investigated
disease (HD) is a neurodegenerative disease

3, 107

polyglutamine-coding CAG repeat in the HTT gene

106

. Huntington’s

caused by the expansion of a

108-112

. The first 17 amino acid residues

of htt (Nt17 of htt) are thought to play an important role in the protein’s function; Nt17 is one
of two membrane-binding domains in htt. The Nt17 peptide is intrinsically disordered in

10

solution and it undergoes a conformational shift from unstructured to an amphipathic αhelix in the presence of a membrane

6, 111, 113-114

Nt17 peptide a lipid-binding domain for htt

. This conformational change makes the

115

. It is believed that the amphipathic

characteristic of the peptide causes the more hydrophilic residues to face toward the polar
solvent and the more hydrophobic residues to face toward the lipid vesicles

116

. The

composition of the lipid vesicle plays an important role in this interaction as the peptide
displays greater affinity towards phosphatidylcholine (PC) lipid vesicles

111, 117-118

. Overall,

the peptide is shown to have a greater propensity to interact with vesicles of
phosphatidylcholine (PC) rather than phosphatidylethanolamine (PE) lipids. Mass spectra
show an increase in lipid-bound peptide adducts where the ordering of the number of such
specie is 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) > 1-palmitoyl-2-oleoyl-glycero3-phosphocholine

(POPC)

>

1-palmitoyl-2-oleoyl-sn-glycero-3

phosphoethanolamine

(POPE). MD simulations suggest that the compactness of the bilayer plays a role in
governing peptide interactions. The peptide shows greater disruption of the DOPC bilayer
order at the surface to interact with the hydrophobic tails of the lipid molecules via
hydrophobic residues. Conversely, the POPE vesicle remains ordered and lipids display
transient interactions with the peptide through the formation of hydrogen bonds with
hydrophilic residues.

The POPC system displays intermediate behavior regarding the

degree of peptide-membrane interaction. Finally, the simulations suggest a helix stabilizing
effect resulting from the interactions between hydrophobic residues and the lipid tails of the
DOPC bilayer.
In Chapter 4, the stability and the role of important residues in oligomeric forms of
PR in a POPE:POPG lipid bilayer and different detergent systems is investigated. Several
residues play a role in the ion pumping process from the cytoplasmic side to the
extracellular side including E108 which acts as a proton donor, the retinol, D97 which acts

11

as a proton acceptor, and E142 which is the proton releaser. In the dark state where no
photon is illuminated, all these residues are in their ground state119-120. It has been
suggested that the native state of the protein is a pentameric/hexametric form because
these oligomeric forms are dominant for many detergent/lipid conditions. The protein
obtains structural stability upon forming noncovalent interactions between the monomers in
the oligomeric form. In this work molecular dynamics (MD) simulations are utilized to
characterize the effect of different membrane environments on the stability of PR in the
dark state. Dodecylphosphocholine (DPC), 1,2-dihexanoyl-sn-glycero-3-phosphocholine
(DHPC), and n-Dodecyl-β-D-Maltoside (DDM) detergent systems along with 1Hexadecanoyl-2-(9Z-Octadecenoyl)-sn-Glycero-3-Phosphoethanolamine (POPE) and 1Hexadecanoyl-2-(9Z-Octadecenoyl)-sn-Glycero-3-Phosphoglycerol (POPG) lipid bilayer
systems are used to study the pentameric/hexameric forms of PR.
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2. Comparison of Peptide Ion Conformers Arising from NonHelical and Helical Peptides Using Ion Mobility Spectrometry
and Gas-Phase Hydrogen/Deuterium Exchange
Reprinted with permission from Journal of American Society for Mass Spectrometry: Comparison of
Peptide Ion Conformers Arising from Non-Helical and Helical Peptides Using Ion Mobility Spectrometry
and Gas-Phase Hydrogen/Deuterium Exchange. Ahmad Kiani Karanji, Mahdiar Khakinejad, Samaneh
Ghassabi Kondalaji, Sandra N. Majuta, Kushani Attanayake, Stephen J. Valentine. J. Am. Soc. Mass
Spectrom. 2018, 29, 12, 2402–2412.

Introduction
Since the discovery of the structure of the α-helix in polypeptides,

1

significant research

has been devoted to determining factors that affect the formation of elements of secondary
structure and in particular those effecting helix formation 2.

Initial efforts, boosted by the

expanding available protein structure data, focused on the relationship between the presence of
α-helices and the frequency of occurrence of specific amino acid residues

3-7

. Shortly later,

Chou and Fasman proposed a method for predicting this secondary structure element using
amino acid sequence information 8. Over the next several decades, interest in helix structure
prediction progressed to the point where a relatively high degree of accuracy was obtained

9-10

.

This progress coincided with efforts to refine helix propensities of the individual amino acid
residues 2, 11-12 and the concept has even been extended to structure destabilization imparted by
D-amino acid residues 13-14.
The rapid increase in the number of experimentally-determined protein structures over
the last three decades

15-16

has significantly enabled protein structure prediction capabilities.

Perhaps, the simplest conception is to use sequence homology based on comparisons to
known structures to infer structural elements for proteins of interest

17-19

. Over the years other

computational techniques have advanced significantly and protein structure prediction efforts
can currently be grouped into those using ab initio methods (or ab initio guided approaches) and

20

template-based methods (fold recognition and threading, comparative modelling)

20

. Currently,

protein structure prediction remains a highly active and rapidly evolving area of research

21-23

.

A challenge in the characterization of polypeptide structure are species that have been
24-26

designated as intrinsically disordered
unstructured regions of proteins

. Although efforts have been developed for predicting

27-28

, recent developments regarding the nature of species

classified as intrinsically disordered have called into question whether or not structural
assessments are possible. One area of interest is the study of peptide structure. For example,
the peptide bradykinin was examined by NMR many years ago and only a small portion of the
molecule was assigned to a β-turn structural type

29

.

Recent experiments that employed ion

mobility spectrometry (IMS) combined with mass spectrometry (MS) have shed some light on
the inability of solution-phase measurements to determine prevailing structural motifs for
peptides; for bradykinin, these experiments revealed the presence of multiple, co-existing
solution structures

30-31

. Although the exact relationship of gas-phase structures to antecedent

solution states is still under investigation, such efforts suggested that gas-phase analyses could
provide insight into the various structures of polypeptides that exist in solution. Interestingly,
extending the approach has suggested the presence of multiple protein structures for species
for which well-defined native conformations predominate

32

.

Results from the early IMS-MS experiments lead to questions regarding the degree to
which elements of secondary structure are preserved in the gas-phase for such dynamic
systems and whether or not solution structures can be derived from high-quality gas-phase
structures. To study this, recent experiments have examined the conformations of [M+3H] 3+
ions of the model peptide Acetyl-PAAAAKAAAAKAAAAKAAAAK (hereafter referred to as the Acontaining peptide) using a combination of IMS-MS and gas-phase hydrogen/deuterium
exchange (HDX) measurements and molecular modeling techniques

33-35

. This peptide was

selected because of its relatively large propensity to form a helix in solution

2, 36-37

. In general,
21

studies suggested that the presence of multiple conformer types of varying degree of helicity
can contribute to the [M+3H]3+ ion conformers that were studied

33

. In many respects, this work

was similar in nature to early efforts aimed at designing gas-phase peptide ion structure 38 as
well as studies that have characterized peptide structural motifs with gas-phase HDX

39-40

.

The present work examines the [M+3H]3+ ions of the model peptide AcetylPSSSSKSSSSKSSSSKSSSSK (hereafter referred to as the S-containing peptide). This peptide
has been designed to exhibit less helical propensity in solution 2. Indeed, because the hydroxyl
oxygen of serine (S) can hydrogen bond with the carbonyl oxygen of the 3rd residue, S is known
to destabilize α-helix structure
helix-breaking structure

41

. Additionally, regions of high S density are associated with

42

. The model peptide was also designed because of the potential to

experience a different process of gas-phase conformation establishment when compared with
the previously studied A-containing peptide. Previous work has suggested that the non-polar A
residues may strongly associate with the a polar vacuum environment during the final stages of
ESI

35, 43

; it may be expected that the S residues will more strongly favor solvent interaction

during the final stages of ESI. These differences offer the opportunity to compare the ion
structure types formed by very different solution conformers and possibly by different processes
of gas-phase conformer establishment.
Overall, ion collision cross section values are nearly the same compared with the Acontaining peptide. However, because the S-containing peptide has a larger molecular weight,
one may conclude the overall structure is more compact.

Additionally, there are significant

differences in the relative accessibility of exchange sites of terminal and middle amino acid
residues with the latter being more accessible to the S-containing peptide. These characteristics
are discussed below using structures obtained from simulated annealing to help provide insight
into relative accessibility.

By providing information about gas-phase ion conformer

establishment from different solution states, these efforts may help to enhance protein structure
22

prediction tools in the future. Finally, this work adds to the growing repertoire of studies that
employ IMS-MS, gas-phase HDX, and/or MD simulation techniques for peptide/protein ion
structure characterization 44-53.

Experimental
Sample Preparation. The model peptide acetyl-PSSSSKSSSSKSSSSKSSSSK (97.3%
purity) was purchased from GenScript (Piscataway, NJ, USA) and used without further
purification. To prepare the 1 mg/mL stock solution, the peptide was dissolved in the appropriate
amount of Milli-Q water. The stock solution was then diluted 10 fold with a 100 mM solution of
ammonium acetate in water to prepare the ESI solutions. This solution was infused (0.5 µL/min)
through a pulled-tipped capillary which was biased ~+2200 V relative to the entrance of the
hybrid IMS-MS instrument.
IMS-HDX-MS Measurements. For the ion mobility measurements conducted here, a dual-gate
drift tube similar to others described in the literature was used

54-55

. The details of the drift time

(tD) and MS measurements have been described in detail previously

56-57

. Briefly, for this study,

ions generated by ESI were periodically (50 Hz) pulsed into a ~1-m-long drift tube that was filled
with ~2.5 Torr of 300 K helium buffer gas. For the dual ion gate approach, the second gate was
set to transmit at specific delay times in order to record mobility-resolved mass spectra. This
delay time was scanned (200 µs increments) across the mobility distribution of the [M+3H] 3+
ions.

Mass spectra were recorded by a linear ion trap (LTQ Velos; ThermoScientific, San

Jose, CA, USA) instrument. A mass-to-charge (m/z) range of 400 to 1000 was employed. For
each tD increment mass spectra were recorded for 0.5 min. For mobility selection, the second
ion gate was set to transmit for 200 µs.

23

The HDX measurements conducted here are modeled after foundational work in which the
reactivities of different biomolecular ions were examined upon reaction with gaseous
deuterating reagent

58-65

.

For HDX measurements, ~0.02 Torr of D2O was added to the buffer

gas. With the addition of D2O, the tD distributions shifted to longer times as shown in Figure 2.1.
Therefore, for the tandem MS (MS/MS) measurements, the delay times were scanned across
the tD distributions obtained when employing D2O to determine the mobility selection time
corresponding with the dominant, compact conformer type for the [M+3H] 3+ ions. As it was
desired to examine the HDX behavior of the dominant, most compact ion conformer type,
mobility selection was initiated 200 µs prior to the peak maximum time point in order to minimize
contamination from larger ions (Figure 2.1).

24

Figure 2. 1 tD distributions for the [M+3H]3+ ions of the model peptide AcetylPSSSSKSSSSKSSSSKSSSSK.
The bottom and top traces show the distributions obtained in the absence of D 2O and after the
introduction of ~0.02 Torr D2O. For both distributions, a delay step time of 200 µs was used and
each mobility-resolved spectrum was collected for 0.5 min. Integration of the isotopic envelope
for the [M+3H]3+ ions at each delay time setting provided the intensity values for the
distributions. The distributions have been normalized to show relative intensities. The red bar
in the top trace shows the typical mobility selection time and width.

25

Peptide Ion Dissociation by ETD and Per-Residue Deuterium Uptake Calculations. The MS/MS
analyses described here have also been influenced by foundational work demonstrating the
utility of MS/MS to determine deuterium uptake from gas- and solution-phase experiments

66-68

Briefly, mobility-selected [M+3H]3+ ions were subjected to electron transfer dissociation (ETD)
to determine the per-residue deuterium incorporation as described previously

.

69

56, 70

. To perform

ETD measurements, mobility-selected ions were isolated by m/z and the ion injection time was
maintained at 200 ms (5 microscans). Because ETD did not generate a number of lower m/z
ions, the deuterium uptake value for each residue was obtained using both z- and c-type ions.
The per-residue deuterium uptake values for the fragment ions were obtained by first
subtracting the average mass of the fragment ions obtained in the absence of D2O from the
average mass of those generated upon using D2O reagent gas. For the triplicate
measurements, the amount of deuterium incorporated in each residue was calculated by
subtracting the deuterium uptake values of the appropriate adjacent fragment ions. Here it is
noted that mass spectrometer conditions including all focusing optics were maintained at
conditions that have been shown to not induce deuterium scrambling

71

.

Molecular Dynamics (MD) Simulations. Details regarding the in-vacuo MD simulations can also
be found in the prior, related work

72

. Briefly, the initial structures of the [M+3H]3+ ions for

simulated annealing were generated using the Visual Molecular Dynamics (VMD). The
CHARMM36 force field was employed for structural parameterization. All of the parameters
were defined in this force field. The CNEU patch in the top_all36_prot topology file were used to
protonate the C-terminal K residue resulting in a +1 formal charge. The LSN patch was used to
protonate the more N-terminal K residues. Acetyl groups were attached to the N-terminus
portion of the P residue by using the ACP patch. 5000 steps of geometry and energy
minimization were carried out using the Nanoscale Molecular Dynamics (NAMD) software suite
for the [M+3H]3+ peptide ions with charge arrangements of K(6)-K(11)-K(16), K(6)-K(11)-K(21),

26

K(6)-K(16)-K(21) and K(11)-K(16)-K(21). Then, the structures were subjected to cyclic simulated
annealing (SA) for conformational space sampling. For SA runs (timestep of 1 fs), the
Berendsen temperature coupling algorithm was used. For the SA algorithm, the temperature of
the in-vacuo system was suddenly increased to 1010 K over 10 steps. The heated structure was
maintained at that temperature for 40 ps and then cooled to a lower temperature (10 K) over two
different timescales (40 and 1200 ps). The annealed structures were subsequently energy
minimized to 0 K to generate candidate structures. The energy minimized structure of each
cycle was imported as the starting point for the next heating-cooling cycle. Each minimized
structure was gradually heated to 300 K and equilibrated. The structures then undergo 5 ns of
MD simulations with no non-bonded cutoffs for long-range interactions while the temperature
was constant. The Mobcal software suite
section values using the trajectory method

73

was used to calculate theoretical collision cross-

74

.

Hydrogen Accessibility Scoring (HAS) and HDX Kinetics Modeling. HAS scores were calculated
for in-silico structures with matching collision cross sections. Two candidate structures which
contained CCS values matching experimental measurements were selected for discussion. The
selection was based on a first-pass examination of HAS scores for which one ion structure
displayed increased proximity of charge sites to middle residues while the other displayed less
access to these residues (see discussion below) as is suggested to be required by the “relay”
mechanism for HDX

75

. Hydrogen accessibility was computed as described previously

76

where

each carbonyl site was scored based on its relative access to charge sites on the hypothetical
peptide ions. Then the distances between exchange sites and these scored carbonyls were
used to obtain relative theoretical reactivities of each exchange site which were summed for
individual residues to provide a residue score. Finally, the residue scores were scaled based on
relative values of surface accessibility using the solvent accessibility surface area (SASA)
approach in the VMD software suite. Using these residue scores, the deuterium incorporation

27

was estimated for [M+3H]3+ ions using an HDX kinetics model described previously

56

. Briefly, a

population of ions (1000) was stepped (1 µs) through a mobility separation (~10 ms) and the
exchange nature of each site was computed at each step based on the contribution of the
residue to the overall rate of exchange for the ions. After stepping all ions through the mobility
separation time, the HDX simulation algorithm determined the amount of deuterium
incorporation for each residue; this theoretical uptake value is compared to the experimental
results below.

Results and Discussion
Peptide Ion Collision Cross Sections. Summing the spectral counts for the [M+3H] 3+ peptide
ions at each mobility selection allows the generation of the tD distribution shown in Figure 2.1
(bottom trace). The distribution is dominated by a feature having a tD of ~8.5 ms. A shoulder,
indicating the presence of larger ion conformer types is also observed. With the addition of
~0.02 Torr of D2O, the entire distribution shifts to longer times. The dominant peak is observed
to have a tD of ~9.3 ms representing a shift of ~0.8 ms. Again, a shoulder of similar intensity is
observed at longer tD values. The shift in the shoulder feature is also observed to be of the
same magnitude. That the distribution is similar in the presence and absence of D 2O suggests
that the HDX process does not result in structural transformations and it is therefore possible to
monitor the reactivities of select ion conformer types. This is similar to results that have been
presented for protein ions 60.
From the ion tD distribution, it is possible to determine the collision cross section of the [M+3H] 3+
ions. Collision cross sections are determined using Equation 1

Ω=

(

) /
(

) /

[

+

]

/
.
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:
Equation 2. 1
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In Equation 1, ze and kB are the charge of the ion and Boltzmann’s constant, respectively. The
variables mI and mB are the mass of the ion and the mass of the buffer gas, respectively. E, L,
T, and P represent the electric field, the length of the drift tube, and the temperature and
pressure of the buffer gas, respectively. Finally, N is the neutral number density at standard
temperature and pressure (STP) conditions. Using Equation 1, the

He

ΩDT (DT = linear drift tube)

is determined to be 424 Å2 and 464 Å2 for the prominent feature and shoulder, respectively.
These values are larger but similar to those determined for more compact and partially-unfolded
A-containing peptide conformers (417 Å2 and 438 Å2) 34, 76.
A goal in examining the model peptide ions is to begin to determine the degree of similarity in
solution- and gas-phase peptide structure in order to better understand ion conformer
establishment. A number of studies suggest that a high degree of structure preservation is
observed for relatively small proteins

78-79

. The fate of even smaller peptide ions is less clear.

As mentioned above, comparisons of the data reported here for the S-containing peptide are
made with those obtained from previous studies of the A-containing peptide because of
expected differences in predominant solution conformers. Indeed, CD spectroscopy of the Acontaining peptide suggests a high-degree of helical character as indicated by the negative
bands at ~207 and 223 nm as well as the positive band at ~190 nm shown in Figure S1 in the
Supplementary Information section (Appendix A).

The CD spectrum for the S-containing

peptide (Figure S1 in the Supplementary Information section (Appendix A)) shows a very clear
difference in predominant solution structure for this peptide where the features indicating α-helix
are clearly missing and a broad band at lower wavelengths is indicative of more random coil
character.
Because of these differences in solution structure, it is of interest to consider the compact ion
conformers for both the S- and A-containing peptides. Notably, the collision cross section of the
S-containing peptide is only ~1.7% larger than that of the A-containing peptide ion (see above).
29

This occurs even though the molecular weight of the S-containing peptide is ~14.1% larger than
that of the comparative peptide. Thus, the overall gas-phase “packing” of the S-containing
peptide is more extensive than that of the A-containing peptide. This increased atom density for
the S-containing peptide ions offers the opportunity to determine whether or not distinctive HDX
behavior can be observed that would be consistent with such ion structures. Thus for the Scontaining peptide, the residue specific deuterium content was examined in detail; the
deuterium content was then compared to that of the A-containing peptide and the results are
discussed below. Here it is noted that it was not possible to compare the more elongated
conformer of the [M+3H]3+ ions as the signal level for the mobility-selected ions was insufficient
to obtain ion fragmentation spectra.
Per-residue Deuterium Uptake. Upon introduction of D2O to the drift tube, the m/z of the
[M+3H]3+ ions shifted to higher values (m/z~695.4) indicating the incorporation of 20.1
deuteriums (19.9±0.9, on average). Overall there are 48 exchangeable hydrogens (including
the three protonation sites).

Thus, ~41% of the exchangeable hydrogens are observed to

undergo exchange. This is similar to the level of deuterium incorporation observed for the Acontaining peptide

76

. Therefore, it is useful to consider the amount of deuterium incorporation

occurring at the neutral S and A residues. Notably, because the ETD approach used here does
not differentiate between side-chain and backbone sites, the question of relative accessibility of
different site types for the S residues cannot currently be answered.

However, a semi-

quantitative comparison of residue accessibility can still be achieved based on the per-residue
deuterium content.
To determine the S-residue deuterium content for the gas-phase HDX studies, the more
compact [M+3H]3+ precursor ions were mobility selected and subjected to ETD both before and
after introduction of the D2O reagent gas.

Figure 2.2a shows the fragmentation spectrum

produced for the unlabeled ions. Two strong features are observed at m/z~688.7 and
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m/z~1032.5 and correspond to the [M+3H]3+ precursor ions and the charge-reduced, doublycharged ions. Overall, a general lack of low-m/z ions is observed in the fragmentation spectrum;
dataset features for the z4 through z20 and the c6 through c20 fragment ions are observed.
Observed ions used in deuterium content calculations with their associated m/z values are
provided in Table S1 in the Supplementary Information section (Appendix A). Because many
lower m/z fragment ions are not observed, the deuterium uptake values for individual amino acid
residues have been determined using a combination of c and z ions. There are two advantages
in using both c and z ions to obtain the uptake values.

The first is that nearly complete

sequence coverage can be obtained and the second is that a double check of deuterium uptake
is provided especially for dataset features of lower intensity.
After undergoing gas-phase HDX, the fragment ions produced by ETD broaden due to an
increased number of isotopologues and shift to higher m/z values as shown in Figure 2.2b. In
the case of the z ions, by subtracting the 𝑧

ion from the 𝑧 , the deuterium uptake value for the

residue numbered 𝑁 − 𝑖 − 1 can be determined for which N is the number of total peptide
residues (21 in this case). For the c ions, by measuring the difference between the 𝑐

and the

𝑐 ions, the deuterium content of the residue number i can be calculated. For example, the
average m/z for the peak corresponding to z15 ions is 1432.68 and the same peak when D2O is
introduced is m/z 1445.40. Thus the deuterium content is calculated to be 12.72. Another
example in Figure 2.2 is the c6 ions. In this case the average m/z is 633.70 and the
corresponding average m/z in the presence of D2O is 638.78.

Here the deuterium content is

5.08. Table S1 in the Supplementary Information section (Appendix A) provides the deuterium
uptake values for the amino acid residues obtained from the z and c ion fragments.
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Figure 2. 2 Ion fragmentation spectra obtained upon ETD of the [M+3H]3+ ions of the model
peptide Acetyl-PSSSSKSSSSKSSSSKSSSSK.
a) Shows a typical ion fragmentation spectrum for ions that are not exposed to D 2O in the drift
tube. b) Shows a typical ion fragmentation spectrum for ions that have been exposed to D 2O in
the drift tube. Several c and z ions are labeled with arrows indicating their location in both
spectra.
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To provide further insight into the determination of deuterium uptake, it is instructive to examine
expanded regions of the mass spectra shown in Figure 2.2. Figure S2 in the Supplementary
Information section (Appendix A) shows expanded regions for three fragment ions. In general,
as the fragment ion mass increases, an increased shift to higher m/z is observed and a wider
isotopic distribution is encountered for ions produced after HDX (Figure S2 in the
Supplementary Information section (Appendix A)). For fragment ions produced after HDX, the
average m/z value is computed by locating the dataset feature edges (typically ≤20% peak
height) and then computing the weighted average of the isotope peaks between the edges. The
average m/z of the fragment ion produced prior to introduction of D2O is then subtracted from
this value to obtain the overall m/z shift resulting from deuterium incorporation.
S- and A-residue deuterium content comparison.

To investigate whether the per-residue

deuterium content reveals differences in relative residue accessibility between the S- and Acontaining peptides, the per-residue deuterium content is here compared. As mentioned above,
one comparison that is readily available is that of overall HDX efficiency for these resideus. For
the S-containing peptide, on average, the number of deuteriums incorporated for all S residues
is ~9.4 (~28.5% of the 33 total available). For the A-containing peptide, a value of ~19.5%
efficiency (~3.3 of 17 available sites), on average, is obtained. The higher efficiency could be
reflective of the more compact nature of the S-containing peptide as more exchange sites are in
closer proximity to charge sites and deuterium incorporation sites as required by the reaction
mechanism 75.
For the reactivity comparisons at the per-residue level, a question arises as to how the
evaluation should be performed.

For example, the S-containing peptide contains 16 more

exchangeable hydrogens due to the side-chain site on the S residues when compared with the
A-containing peptide ions. Therefore a direct comparison of per-residue deuterium content may
not provide the simplest representation of the relative accessibility. Thus the S and A deuterium
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content values are scaled according to their fractional values of the total deuterium incorporated
into the neutral residues. K residues are not included in this analysis because, considering the
HDX mechanism, different charge site configurations could contribute to the observed
differences. Here, rather the interest is in comparing the average differences in accessibility to
different regions of the peptide through the use of the S and A residues.
Figure 2.3 shows the comparison of the deuterium content of the S and A residues on the
respective peptide ions. For the A-containing peptide, only four residues show significantly
greater accessibility; these are the A4, A5, A19 and A20 residues. For the S-containing peptide,
the residues showing significantly increased accessibility are the S2, S9, S10, S13, S15, and
S17 residues. Overall, the results suggest a greater accessibility to middle residues for the Scontaining peptide ion. This could result from increased charge solvation by the S residues as
discussed below. Notably, the relative per-residue deuterium uptake values shown in Figure 2.3
exhibit different levels of precision (also shown as independent values in Table S1).

This

appears to primarily result from variability in determining the peak centers of low abundance
fragment ions. For example, fragment ions used to determine the deuterium content for S3 and
S18 residues are ~40% lower in intensity relative to those used for the S13 and S19 residues.
That said, the error levels are in line with those reported previously

72, 76, 80-81

.
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Figure 2. 3 Bar graph showing the fraction of deuterium for S (red bars) and A (blue bars)
residues obtained from MS/MS analysis of mobility selected ions.
Fractional values are calculated as the ratio of the deuterium content of the specified residue to
the total deuterium content from neutral residues for the respective peptides. Error bars are
obtained by propagating the error (one standard deviation) of the individual deuterium uptake
values.
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Comparison to candidate structures from MD simulations.

The HDX behavior of the S-

containing peptide was further considered using MD simulations. To find the best structural
type (or types) exhibiting similar exchange site accessibility to the gas-phase conformer type,
simulated annealing was conducted for [M + 3H] 3+ peptide ions using two different charge
configurations as well as two different simulation times (see Experimental section). As shown in
Figure S3 in the Supplementary Information section (Appendix A), the collision cross sections
obtained from MD simulations are, for the most part, significantly smaller than the experimental
value. An examination of some of these structures, reveals extremely compact ion conformer
types with significant charge solvation of the charge sites by the serine residues as shown in
Figure S4 (Supplementary Information section (Appendix A)). Indeed, as an indicator of how
the MD simulations captured such charge solvation, consider that only 71 of 8000 structures
were observed to have collision cross sections within ±2% of the experimental value for the
compact [M+3H]3+ ions.
To consider which of the structural types with matching collision cross sections best represented
the experimental data, HDX kinetics modeling was employed (see Experimental section above).
Notably, this work does not include the very extensive MD trajectory modeling that was
performed previously for the A-containing peptide

34-35, 76

. Rather, here the MD simulations are

only performed to provide an idea of conformer types that could account for the observed HDX
accessibility

72

.

From HAS scoring and kinetics modeling of the 71 structures, several

conformer types appeared to exhibit significant charge solvation by middle residues. Based on
the best ability to match the experimental results (see below), one of these ion structures was
selected for discussion. This ion structure is shown in Figure 2.4C.
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Figure 2. 4 The comparison of the experimental and theoretical fraction deuterium incorporated
values.
Panel A shows the comparison of the experimental fraction deuterium incorporated values (blue
bars) and the theoretical fraction deuterium incorporated values (red bars) for the ion
conformation shown in panel C of the model peptide Acetyl-PSSSSKSSSSKSSSSKSSSSK.
Panel B shows the same comparison for the ion conformation shown in panel D. In panels C
and D, several residues are labeled to demonstrate their relative accessibility for HDX (see text
for details).
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The agreement between experimental and theoretical (HDX kinetics modeling) relative
deuterium content is shown as a bar graph in Figure 2.4A. A number of trends are shown to
agree between the experimental and theoretical values. Here we note that the theory favors
sites that are in relative proximity to backbone carbonyls that are in relative proximity to charge
sites. A trend captured by the theory for the first ion conformer is the relatively low levels of
uptake for S3 and S4 and an increase in uptake for S5 and S7. This is followed by a slight
decrease for S8 and then increases for S9 and S10. The model slightly overestimates the
deuterium content for S12 to S14. This is followed by relatively good agreement between S15
and S17. The worst agreement is observed at the C-terminal and N-terminal ends for the S2,
S18, and S20 residues. Overall, the average percent difference between experiment and theory
is observed to be ~27.5% across all S residues.
Figure 2.4D shows a separate ion conformer for which increased accessibility is observed for
the terminal peptide portions relative to middle residues. For example, for this ion conformer
there is an increase in estimated deuterium content for the N-terminal residues S3, S4, and S5
with an increase also observed for the C-terminal residues S18, S19, and S20.

These

increases are offset by decreases in theoretical deuterium content for residues S7 to S14 as
well as S17. For this structure, the average percent difference between experiment and theory
is ~41.4%.
The differences in the quality of HDX reactivity matching for the ion candidate structures can be
described via the HAS scores and the structure images shown in Figure 2.4. For the ion
structure providing the best HDX reactivity matching, the charge site assignments are K6, K16,
and K21 while the charge site assignments for the second ion structure are K6, K11, and K21.
One noticeable difference in the structures is that the former ion conformer with its charge
arrangement exhibits less charge density. Indeed, the relative Coulomb energy of the former
ion conformer is only 69% that of the latter. Thus a more even dispersion of charge throughout
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the ion conformer is observed. For the first ion conformer (Figure 2.4C), the relative increase in
theoretical deuterium content would be elevated for the S17 residue due to its hydrogens
proximity to the S13 (2.9 Å), S14 (2.1 Å), and S17 (3.6 Å) carbonyls. These carbonyls are
highly scored because they are in close proximity to the K21 charge site (all ≤1 Å) and the S13
carbonyl is also within 2.5 Å of the K16 charge site. The S15 residue has a large theoretical
deuterium uptake as well due to its hydrogens proximity to the K11 (1.9 Å), S12 (3.0 Å), and
S14 (3.1 Å) carbonyls. The K11 and S12 carbonyls are scored highly because they are within 3
Å of the K16 and K21 charge sites.

In comparison, only one scored carbonyl is positioned at

≤4 Å from the S19 hydrogens. The increased theoretical deuterium uptake for the S10 to the
S14 sites results from the fact that these residues fall between the K6 and K16 charge sites and
there is a significant compaction of this portion of the ion such that exchange sites are in close
proximity to a greater number of carbonyl sites. For example, the S10 residue has hydrogens
that are within 1.8 Å and 2.9 Å of scored carbonyls on the S4 and S7 residues. Additionally,
labile hydrogens are ≤4 Å of scored carbonyls on the S8 and S9 residues. These scored
carbonyls are in closer proximity to the K6 charge site. Finally, although the S2, S3, and S4
residues are in relative proximity to the K6 charge site, there is a decreased number of close
carbonyl sites. For example, for hydrogens on the S2 residue, only the S2 carbonyl is within ≤4
Å.
For the ion conformation presenting decreased agreement in theoretical and experimental
deuterium content (Figure 2.4), the decrease at S2 results from the placement of this residue
further away from charge sites. This is evident from the fact that the only carbonyl sites within 4
Å of any hydrogen on the S2 residue are the N-terminal acetyl group and the P1 residue and
both of these carbonyls are not highly scored due to their distance to charge sites. Decreases
in middle residues S9 and S10 can be seen to result from the placement of these residues
further away from charge sites and scored carbonyl sites. For example, hydrogens on the S10
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residue only encounter the S8 carbonyl at a distance that is ≤ 4 Å. Finally, the increased
theoretical deuterium content at the C-terminal residues (S18, S19, and S20) results from the
fact that these residues are in close proximity to the K6 and K21 charge sites as well as a
number of carbonyl sites. For example, the hydrogens on the S19 residue are within 1.5 Å and
2.5 Å of the scored carbonyls on the S18 and S19 residues. These carbonyls are scored highly
as they are 0.5 Å and 1.7 Å from the K21 charge site. Additionally, the latter carbonyl is also
within 5.7 Å of the K6 and K11 residues. As shown in Figure 2.4, the structure exhibiting the
decreased HDX reactivity match appears to position the S4 and S5 residues such that they
would not exhibit greater accessibility as determined by the HAS approach. However, upon
rotation of the ion structure, it becomes apparent that the exchangeable hydrogens on the S4
and S5 residues are near a number of highly scored carbonyl sites as shown in Figure S5 in the
Supplementary Information section (Appendix A). Indeed, the hydrogens on these residues are
≤ 2 Å from the N-terminal acetyl group carbonyl and the P1 carbonyl.
It is instructive to consider the type of ion structure that would be required to result in increased
exchange of the S2 and S20 residues as is observed experimentally (Figure 2.4).

One

consideration is that more compact structures in which the N-terminal and C-terminal ends turn
back toward the middle residues would provide increased HAS scores for these residues.
Figure S6 in the Supplementary Information section (Appendix A) shows a compact ion
structure (HeΩDT = 363.0 Å2) for which HAS scoring and HDX kinetics modeling was performed.
The relative deuterium incorporation levels for several residues are also shown in Figure S6
(Appendix A). Notably, the value for the S20 residue is the largest of all residues and that of S2
is among the largest values as well. Additionally, the deuterium incorporation values for the
neighboring S4 and S18 residues are among the lowest. These results are similar to what is
observed experimentally for N- and C-terminal residues (Figure 2.3 and Figure 2.4). The high
value for the S2 residue results from the fact that a N-terminal bend positions this residue such
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that the S2 backbone hydrogen is in relatively close proximity of the acetyl carbonyl (3.3 Å), the
P1 carbonyl (3.1 Å), and the S2 carbonyl (2.1 Å). These carbonyl sites also have relatively high
scores as they are located near the K6 charge site. The side-chain hydrogen of S2 is located
near (1.7 Å) the S10 carbonyl which is one of the highest scoring carbonyl sites being near
multiple charge sites. In contrast, the backbone hydrogen and the side-chain hydrogen of the
S4 residue are not within 3 and 4 Å, respectively, of any scored carbonyl. For the S20 residue,
hydrogens are in close proximity to the highly scored carbonyls on S19 (3.1 Å) and S8 (2.0 Å).
The S18 residue hydrogens are not within 3 Å of any scored carbonyl.
It is necessary to present a note of caution regarding the comparisons between theoretical and
experimental deuterium uptake here. Such comparisons are not intended to be definitive as
they do not consider ion conformer dynamics or the possible contribution by multiple ion
conformers with different charge site configurations. As mentioned above, the failings of the
approach are especially obvious in the inability of either ion structure to account for the
increased deuterium content of the S2 and S20 residues observed experimentally.

The

improved matching of HAS scores with experimental values for these residues when using a far
too compact ion structure is intriguing. For example, such analysis may suggest that multiple
ion conformer types comprise the mobility selection and a portion of these contain bends at
either the N-terminal or the C-terminal end with the other end extended (in order to exhibit the
correct cross section).

That said, the comparisons are useful insofar as they demonstrate

conformer types exhibiting specific charge solvation that could account for the observed
differences in relative deuterium content of specific peptide regions.

Additionally, such

comparisons represent the foundational work that will be extended to exhaustive MD
simulations that do account for conformer dynamics as well as the presence of different
conformer types. In future works, such simulations will be conducted in the gas and solution
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phases as was performed for the A-containing peptide

34-35

and the results will be compared with

regard to the preferred types of structure formed for the different ions.

Conclusions
IMS-HDX-MS/MS measurements coupled with MD simulations have been used to gain insight
into the behavior of [M+3H]3+ ions of the model peptide Acetyl-PSSSSKSSSSKSSSSKSSSSK.
From the IMS measurements a dominant, compact ion conformer is observed. In comparison to
the same ions for the model peptide Acetyl-PAAAAKAAAAKAAAAKAAAAK, the S-containing
peptide is observed to be relatively more compact. This may be somewhat expected as CD
spectroscopy suggests that the former peptide exhibits more random coil nature while the Acontaining peptide exhibits significantly more α-helical character.

In addition to, and likely

attributed to, the increased compactness, the S-containing peptide shows increased
accessibility of interior residues to gas-phase HDX.

MD simulations suggest that ion

conformers demonstrating specific, relatively disperse charge solvation by interior residues
could account for the observed HDX behavior of the [M+3H] 3+ ions.
The disparity in hypothetical and experimental deuterium uptake suggests the need for highly
extensive MD simulations to better understand the contributions of ion structure dynamics as
well as contributions from multiple ion conformers. This limitation was also encountered for the
A-containing peptide where exhaustive gas-phase and ESI droplet simulations have been
conducted to better fit the experimental data

34-35

. Thus, in order to gain insight into the ion

structures resulting from very different solution structures, it will be necessary, in future studies,
to conduct these same exhaustive analyses where a convergence between gas-phase ion
structures and those emerging from ESI droplets is obtained. With these structures it will be
possible to compare the major differences in structures arising from the S- and A-containing
peptides. The comparison of such predominant structures could provide information about the
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degree of preservation of secondary structure for these smaller biomolecules and could thus
help with our understanding of the process of gas-phase ion structure establishment.
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3. Investigating the interactions of the first 17 amino acid
residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics
Reproduced with permission from the Journal of Mass Spectrometry: Investigating the interactions of the
first 17 amino acid residues of Huntingtin with lipid vesicles using mass spectrometry and molecular
dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A., Legleiter, J. and Valentine, S. J.
Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019 John Wiley & Sons, Ltd.

Introduction
The majority of cell membrane volume in biological systems is occupied by lipids and
proteins. The interactions between such components within complex systems have been
studied for years 1-5. Protein/peptide interaction with the membrane at its surface is an important
topic in many fields of study including drug delivery, cell-cell recognition, signal transduction, as
well as the study of disease processes

6-16

.

Peptides that interact with the plasma membrane through processes of traversal, fusion,
or residing directly at the membrane surface interface are termed membrane active 17. It has
been suggested that the manner in which the peptide locates within the membrane is highly
dependent on the membrane lipid composition18. Broadly categorized, the interactions have
been described as the “barrel-stave” and “carpet” mechanisms 17. The former process involves
the insertion of the peptide into the membrane core while the latter involves binding at the
surface primarily through interactions with the polar head groups.
Recently a special type of peptide-membrane interaction has come under increased
examination. This involves peptides that form amphipathic helices. In general amphipathic
helices are polypeptide regions that form a helix upon interacting with hydrophilic/hydrophobic
interfaces.19 A characteristic of such protein regions is the regular incorporation of non-polar
amino acid residues at every third for fourth position. This allows the helix to form in which the
48

non-polar face interacts with the lipid constituents of the membrane while the polar face is
positioned in the aqueous environment. This anchors the protein to the membrane and orients
the helical region parallel to the surface19.
Huntington’s disease (HD) is one of several neurological conditions characterized by
Huntingtin protein (htt) fibril formation in brain tissue. Fibril formation is caused by a
polyglutamine (polyQ) expansion occurring in the N-terminal region of the htt

20

. Studies have

shown that the first 17 amino acid residues (Nt17) as well as a downstream proline-rich region
of htt play important roles in protein stability as well as sub-cellular localization
peptide is suggested to play an important role in fibril formation

26

21-25

. The Nt17

in which the self-association

of the peptide favorably positions the expanded polyQ tracts for aggregation. The subcellular
location of htt, necessitates its interaction with the lipid membrane bilayer and is mediated by
posttranslational modifications of Nt17 residues

27-29

. Additionally, the interaction of Nt17 with

the lipid membrane bilayer has been shown to be an important factor in protein aggregation in
HD 14, 30-32 where Nt17 can participate in lipid-binding as well as protein-protein interactions.
The location of hydrophobic residues (L4, L7, A10/F11, L14, and F17) within the primary
sequence of the Nt17 peptide suggests a propensity to form an amphipathic helix at the lipid
membrane surface. This is supported by recent solid-state NMR studies which suggest that the
peptide lies horizontally along the membrane surface33. A recent study by Mousseau et al.
examined effects of the Nt17 peptide on a phospholipid bilayer

34

. The per-residue helix

propensity in the presence of the POPC lipid bilayer was compared with the NMR structure.
Overall general agreement was achieved for the two models; however, the MD study suggested
that residue numbers 1–4 are more ordered because they are less accessible to the solvent.
Here we present studies of the interaction of Nt17 with the different lipid bilayer systems
[1,2-dioleoyl-sn-glycero-3-phosphocholine

(DOPC),

1-palmitoyl-2-oleoyl-glycero-3-

phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3 phosphoethanolamine (POPE)]
49

using native mass spectrometry (MS)

35

and molecular dynamics (MD) simulations. MS reveals

that Nt17 has a different propensity for interaction with vesicles of different lipid compositions.
The data suggest that the level of peptide interaction is DOPC > POPC > POPE. Modeling
these peptide-lipid systems using MD simulations also supports this interpretation of the MS
data and helps to provide a molecular view of the tendency of the peptide to form non-specific
interactions with lipids.
In general, the combined study presented here is representative of a growing body of
work that utilizes native MS with a goal of elucidating protein interactions with lipid
membranes36-40 as well as the effect of such interactions upon biomolecular structure

41

.

Additionally, the work becomes part of a larger body of studies aimed at determining the
mechanisms of aggregation for pathologically-relevant proteins.
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Experimental
Reagents. The Nt17 peptide (>90% purity) was synthesized by GenScript (Piscataway,
NJ,

USA)

and

used

without

further

purification.

The

peptide

sequence

is:

MATLEKLMKAFESLKSF. The peptide was dissolved in ACS/USP absolute ethanol (Pharmco,
Brookfield, CT) at a concentration of 1 mg/mL to make stock solution. The powder lipids (1,2dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3 phosphoethanolamine (POPE)) were obtained
from Avanti Polar Lipids (Alabaster, AL) and dissolved in HPLC grade chloroform (Fisher
Scientific, Fair Lawn, NJ) to yield a 10 mg/mL stock solution for each lipid.

Vesicle Capture-Freeze-Drying (VCFD). Details about sample preparation using the
vesicle production method are provided elsewhere

41

. Briefly, 100 μL of the stock solution

(~1200 µM) for each lipid were dried using a speedvac (Thermo Scientific Speedvac)
50

maintained under nitrogen gas flow. The dried samples were rehydrated in 1 ml of HPLC grade
water with 10 mM ammonium acetate buffer and sonicated for 30 minutes. Then, the samples
were subjected to 10 freeze-thaw cycles using liquid nitrogen and a ~50 °C water bath.
Subsequently, 100 μL of the stock solution of the Nt17 peptide (~100 µM) was added to each
lipid solution. For all samples, lipids were maintained at a final concentration that was ~10 times
greater than the Nt17 peptide. The peptide/lipid complex solutions were stored over night at 37
°C for equilibration. Notably, a limitation of this study is that the physiological concentration of
Nt17-containing protein is largely unknown although it has been estimated to be 0.15 μM in the
cytosol of neural cells54. Experiments here were designed with higher peptide concentrations
(10 μM) to enhance the level of peptide-membrane interactions as well as to abbreviate the
timescale of such interactions as well as peptide-peptide interactions. Notably this approach is
used to study htt aggregation using THT55 and PDA assays56 and to perform CD spectroscopy14
and AFM57 and MS38 measurements.

Electrospray-Mass Spectrometry (ESI-MS). All of the experiments were carried out
using a Q Exactive Hybrid quadruple Orbitrap mass spectrometer (Thermo Fisher, San Jose,
CA). The experiments were conducted using the commercial HESI source available with the MS
instrument. For both ionization sources MS spectra were recorded in positive ion mode over a
mass-to-charge (m/z) range of 500 to 4000. The samples were infused at a rate of 10 µL/min
using a heated syringe and infusion line to ensure that the POPE vesicles did not undergo a
phase transition. The needle was biased at 3,500 V relative to the instrument inlet. The
instrument parameters used for for ESI were: 450 °C for the capillary inlet temperature, 80 V for
the S-lens assembly, 400 ms for the maximum injecting time, 1 × 106 for the AGC, and 70,000
for the MS resolution. Each spectrum was recorded in triplicate for 180 seconds each to ensure
data collection reproducibility. To analyze the MS data, the Xcalibur 2.2 software suite (Thermo
Scientific) was used.
51

A limited number of experiments were performed on a linear ion trap mass spectrometer
(LTQ, Thermo Fisher, San Jose, CA) to examine product ions upon isolation of lipidated species
(see below). For these experiments, the commercial HESI source was utilized and mass spectra
were recorded in positive ion mode using a m/z range of 900 to 2000 m/z). The same flow rate
and needle bias parameters were used for these experiments. Precursor ions were isolated
using a 10 m/z window and no collisional activation was employed.

Molecular Dynamics (MD) Simulations. For MD studies, two types of models were
used.

The first involved initiation with a linear structure to represent the initial interaction

between the peptide and the membrane surface. Because full helix formation at the surface of
the membrane appeared to be an unreachable event because of the long timescale, MD
simulations were also performed in which the peptide was forced to be helical and placed
directly above the membrane. Notably the NMR structure suggests that it is helical at the
surface33. For the latter simulations, the goal was to determine the degree of amphipathic helix
interactions with the different lipid membranes.
For the initial random coil simulation of the Nt17 peptide, the fully linear structure was
built in Avogadro58 and subjected to 10 ns of simulation in pure water. The output was used as
an input file for the Nt17-lipid bilayer simulation. For the helix model, the Nt17 peptide pdb
structure (2LD2) was obtained from the protein data bank website

33

and used as the initial input

file for the MD simulations. The CHARMM-GUI server (www.charmm-gui.org) was used to
create the lipid bilayer system

59

. The peptide was placed above the bilayer in the z axis and

solvated (explicit model) with water. All the simulations were performed in triplicate. The M1
residue at the N-terminus as well as the lysine residues (K6, K9, K15) were protonated. The
carboxylic acid of F17 at the C-terminus and the two glutamic acid residues (E5, E12) were
deprotonated. This provided a net charge of +1 for the modeled peptides. The nano-scale
molecular dynamics (NAMD 2.13) software

60

was utilized to perform minimization and
52

equilibration of the system based on the CHARMM-GUI protocol and CHARMM c36 force field
for lipids and proteins

61

. The protocol consists of 1950 ps minimization and equilibration

process in which restraints from the peptide backbone, lipids, water and ion molecules are
gradually removed in six steps

62

. Parameters for all-atom MD simulations using the periodic

boundary condition were: NPT ensemble, 2 fs for the timestep, 310 K for the temperate and 12
Å for the cutoff. The visual MD (VMD) suite was used to visualize and analyze the simulation
data. The GridMAT-MD script was used to calculate the theoretical area per lipid

63

.

Results and Discussion
Peptide-lipid interactions examined with native MS. Studies have shown that the
presence of the Nt17 flanking sequence in the htt protein is important for membrane interactions
14, 21, 30

. This association has been suggested to serve to anchor huntingtin protein (htt) to the

membrane

64

. To investigate the peptide interactions with DOPC lipid, mass spectra were

recorded for the sample in which the peptide was incubated with the DOPC vesicles. For these
studies, experiments were conducted in duplicate.
Figure 3.1 shows a typical mass spectrum for the DOPC-peptide system. ESI produces
ions of several different charge state for the Nt17-lipid system. In the mass spectrum, the
doubly-charged monomer peptide ions ([M+2H]2+ at m/z ~988) predominate. Dimer, trimer and
tetramer ions for the Nt17 peptide are also observed at m/z ~1317, 1482, 1580, respectively.
These species are of significantly lower abundance (Figure 3.1).
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Figure 3. 1 Full range mass spectrum of the peptide-DOPC system.
For labeling purposes, a large red circle represents a single Nt17 peptide, a green triangle
represents a single DOPC lipid molecule. Insets show expanded regions for a number of
peptide-lipid complex ions. Ion identities are shown as symbol representations. Reproduced
with permission from the Journal of Mass Spectrometry: Investigating the interactions of the first
17 amino acid residues of Huntingtin with lipid vesicles using mass spectrometry and molecular
dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A., Legleiter, J. and Valentine, S.
J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019 John Wiley & Sons, Ltd.
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In addition to the ions described above, ions comprised of peptide-lipid complexes are
also observed. These range in size from peptide monomer to tetramer ions. A complete list of
the observed protein-lipid complex ions is presented in Table 3.1. Notably, monomer peptide
ions with differing numbers of lipid adducts are observed. These range in size from 1 to 7
attached lipids. This relatively high number of adducts could, to some degree, indicate the
propensity of the lipid to interact with this peptide (see discussion below). In addition to these
ions, peptide-lipid complexes which include one lipid attached to dimer and trimer species are
observed at m/z ~1578 and 1678, respectively, Figure 3.1). Table 3.1 shows the multimeric
peptide-lipid ions that have been observed in these studies. In general, the number of separate
ions as well as the number of attached lipids decreases with higher order peptide multimer. For
example, >1 lipid adduct is observed for all the peptide multimers except for the tetramer where
only 1 lipid is attached (Table 3.1).

55

Iona

m/zb

Nt17 + 1DOPC
Nt17 + 1DOPC
1Nt17 + 2DOPC
Nt17 + 2DOPC
Nt17 + 3DOPC
Nt17 + 4DOPC
Nt17 + 5DOPC
Nt17 + 6DOPC
Nt17 + 7DOPC
2Nt17 + 1DOPC
2Nt17 + 1DOPC
2Nt17 + 2DOPC
2Nt17 + 2DOPC
2Nt17 + 3DOPC
2Nt17 + 3DOPC
2Nt17 + 4DOPC
2Nt17 + 4DOPC
2Nt17 + 5DOPC
2Nt17 + 5DOPC
2Nt17 + 5DOPC
2Nt17 + 6DOPC
2Nt17 + 7DOPC
2Nt17 + 8DOPC
3Nt17 + 1DOPC
3Nt17 + 1DOPC
3Nt17 + 1DOPC
3Nt17 + 2DOPC
3Nt17 + 2DOPC
3Nt17 + 3DOPC
3Nt17 + 4DOPC
3Nt17 + 4DOPC
3Nt17 + 5DOPC
3Nt17 + 5DOPC
3Nt17 + 6DOPC
3Nt17 + 7DOPC
3Nt17 + 8DOPC
4Nt17 + 1DOPC
4Nt17 + 1DOPC

2760.64
1380.82
3546.24
1773.62
2166.42
2559.22
2952.02
3344.82
3737.62
2367.84
1578.89
2760.84
1840.76
3153.44
2102.62
3546.24
2364.49
3939.04
2626.36
1970.02
2888.22
3150.09
3411.96
3354.86
2236.90
1677.93
2498.77
1874.33
2070.73
3022.50
2267.13
3284.37
2463.53
2659.93
2856.33
3052.73
2894.92
2171.44

a

Charge
state
1
2
1
2
2
2
2
2
2
2
3
2
3
2
3
2
3
2
3
4
3
3
3
2
3
4
3
4
4
3
4
3
4
4
4
4
3
4

Iona

m/zb

Nt17 + 1POPC
Nt17 + 1POPC
Nt17 + 2POPC
Nt17 + 3POPC
Nt17 + 4POPC
Nt17 + 5POPC
Nt17 + 6POPC
2Nt17 + 1POPC
2Nt17 + 1POPC
2Nt17 + 2POPC
2Nt17 + 3POPC
2Nt17 + 4POPC
2Nt17 + 5POPC
3Nt17 + 1POPC
3Nt17 + 2POPC
3Nt17 + 1POPC
3Nt17 + 2POPC
4Nt17 + 1POPC

2734.63
1367.81
1747.61
2127.40
2507.2
2886.99
3266.79
2354.83
1570.22
1823.42
2076.61
2329.81
2583.01
2228.23
2481.43
1671.42
1861.32
2164.93

Charge
state
1
2
2
2
2
2
2
2
3
3
3
3
3
3
3
4
4
4

Iona

m/zb

Charge
state

Nt17 + 1POPE
Nt17 + 1POPE
Nt17 + 2POPE
Nt17 + 3POPE
Nt17 + 4POPE
Nt17 + 5POPE
2Nt17 +1POPE
2Nt17 + 1POPE
2Nt17 + 2POPE
2Nt17 + 3POPE

2692.59
1346.79
1705.57
2064.34
2423.12
2781.89
2333.81
1556.21
1795.39
2034.57

1
2
2
2
2
2
2
3
3
3

The following average masses has been used to assign the peaks: 1974.04 for Nt17 peptide, 785.60 for DOPC lipid and 717.54 for POPE lipid.

Table 3. 1 Assigned compounds and their corresponding mass to charge ratio
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Lipid preference of Nt17. The affinity of amphipathic α-helices for lipid bilayers has
been shown to be dependent on the physicochemical characteristics of the membrane

65-67

. One

characteristic showing importance is the packing defects of the membrane. Beyer et al. have
suggested that a small radius of curvature is essential for increasing peptide-membrane
interaction 68. In this study it was suggested that peptide binding to a membrane depends on the
presence of defects in the membrane structure at the membrane-water interface. These shortlived defects create temporary spacing between the lipid head groups which allows greater
interaction between the lipid and the peptide. To investigate this phenomenon further by MS,
experiments were also conducted using DOPC, POPC, and POPE lipid systems. All are
zwitterionic lipids; however, the DOPC lipid contains a much bulkier head group which is
expected to increase the overall area per lipid

69

. Additionally, DOPC and POPE systems have

different lipid tails, that can impact their fluidity at given temperatures. DOPC, POPC, and
POPE have respective phase transition temperatures of -17, -2 and 25 °C. Thus the DOPC
bilayer system is more fluid under experimental conditions (~37 °C) which can more readily
create short-lived defects in the exposed membrane leaflet.
By comparing the mass spectral results from the Nt17-DOPC (Figure 3.1), and Nt-17POPC and Nt17-POPE (Figure S1 in the Supporting Information section (Appendix B)) systems,
it may be possible to obtain some information about differences in types of interaction between
the peptide and the respective lipid vesicles. The assigned peaks for the peptide-PC and
peptide-PE complex ions are listed in Table 1. From Table 3.1, it is readily apparent that the
most lipid adducts are observed in the DOPC system. For example, 1 Nt17 peptide is observed
with up to 7 attached DOPC lipids. Conversely, in the POPE system, only up to 5 lipid adducts
are observed for the monomer peptide. In comparison, this number is 6 for the POPC system.
The greater propensity of the peptide to bind with DOPC extends to the higher-order
oligomers of Nt17. For the DOPC system up to 8 lipid adducts are observed with peptide
57

dimers while this limit is 5 for POPC and 3 for POPE systems. There was no mass spectral
feature corresponding to the peptide trimer and tetramer containing POPE lipid adduct but the
peak for tetramer with one lipid adduct can be seen at m/z ~ 2171.44 for the DOPC system.
Overall, 38 lipid adduct species are observed for the DOPC vesicle system while only 10 related
peaks are observed for the POPE vesicle system suggesting the possibility of a different
interaction type for the former lipid vesicles. Notably, the phenomenon of increased lipid adducts
in the DOPC system is not a result of the relative number of peptide monomers or multimers
believed to form in solution as these are observed in similar abundances for all peptide-lipid
systems. Together these results suggest that differences in interaction between the Nt17
peptide individual lipid vesicles may be responsible for differences in the mass spectra.

Co-mixing Nt17 peptide and lipids without vesicle formation. To investigate the role
of the ESI process on the numbers of Nt17 peptide ions with lipid adducts, experiments were
performed in which the peptide and lipid were co-mixed and, after a similar incubation time,
electrosprayed into the mass spectrometer. More specifically, the Nt17 peptide and lipids were
mixed without any preparation (without sonication and freeze drying) for 5 hours in 10 mM
ammonium acetate buffer. The assigned mass spectral peaks for these datasets are shown in
bold in Table 1. Compared to the experiments in which lipid vesicles were generated before
adding the peptide, in all cases, co-mixing peptide and lipid showed a significantly decreased
number of assigned species. Only 4 ions ([Nt17+1DOPC+H] +, [Nt17+1DOPC+2H]2+,
[Nt17+2DOPC+2H]2+, and [Nt17+3DOPC+2H]2+ at m/z 2760.64, 1380.82, 1773.62, and 2166.42
relatively) were assigned for the Nt17-DOPC system Table 3.1. For the Nt17-POPC and for the
Nt17-POPE systems, only 6 and 3 species were observed, respectively. This indicates that
vesicle formation is an important step to detect elevated peptide-lipid interactions. It also
supports the premise that the mass spectral peak diversity is an indication of solution interaction
as opposed to only processes occurring in the ESI droplets.
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As a final consideration for co-mixing experiments, it is noted that only 2 of 13 assigned
peaks are for Nt17 dimers with lipid adducts.

This could suggest that Nt17 requires a

membrane interface to form increased numbers of oligomeric species and this is revealed in the
MS data. This would be consistent with the concept of mode of action for amphipathic helices
as well as proposed mechanisms of oligomer formation for htt33. That said, caution must be
used in interpreting the mass spectral data as the dataset features could arise in another
manner.

For example, an increased degree of interaction with the lipid membrane could

translate into a large population of adsorbed monomer. During the ESI process, this increased
likelihood of being located at the membrane surface could result in an increase in peptide
numbers within ESI progeny droplets resulting in multimeric ions. Therefore, no conclusions
can be drawn with regard to the degree of membrane-induced oligomerization. To disentangle
the routes of formation for such a heterogenous mixture of oligomeric species is the subject of
future, more extensive experiments employing a greater number of lipid systems as well as gasphase separations and reactivity studies26,
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. This process will also be examined by MD

simulations where multiple peptides are examined with the membrane systems.

This

preliminary study does, however, show that vesicle formation is required to produce a greater
number of oligomer ions with lipids attached in the mass spectrum.

Consideration of peptide-lipid ion intensities. It is instructive to consider the ion
intensities with regard to the degree of interaction between peptides and lipid vesicles. Figure
S2 in the Supporting Information section (Appendix B) shows the relative intensities of the
various ions observed for the three separate lipid systems. Notably, the ions with PE adducts
are of higher intensity especially for those species containing 1 lipid adduct. The question arises
as to the origin of this higher intensity in light of the observation that a greater number of diverse
lipidated species is observed for DOPC and POPC systems. In other words, is this value
reflective of greater interaction overall (independent of type) at the membrane surface? Here, a
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note of caution is raised based on a few observations. First, separate experiments have been
performed on a LTQ mass spectrometer in which the [Nt17+L+2H] 2+ (where L is DOPC or
POPE) ions were isolated in the linear ion trap.

Immediately upon isolation, the DOPC-

containing ions are observed to dissociate to some degree to yield [Nt17+H] + ions. This did not
occur for the POPE-containing ions as shown in Figure S3 in the Supporting Information section
(Appendix B). Based on this observation, it is possible that many ions with differently-oriented
lipid adducts are very fragile and do not survive to the point of mass detection. Additionally, this
could extend to the oligomeric species where a greater number of unique ions is observed for
DOPC (Table 3.1).

Due to such differences, it may not be possible to be fully determine

whether or not ion intensity affords a clear indication of the degree of surface interaction. The
results are presented here as being of interest and worthy of further MS and molecular modeling
studies.

Molecular dynamics (MD) simulations: random coil interaction. To consider initial
interactions between the Nt17 peptide and the lipid membrane, MD simulations were performed
in which the initial peptide structure was random coil (see Experimental Section). To ensure
that the proper parameters had been utilized for the simulations, the area per lipid was
determined as a function of MD trajectory time. These results are shown for the DOPC, POPC,
and POPE lipid systems in Figure 3.2. The average area per lipid values for the respective lipid
systems are 68.6, 65.1, 57.3 Å2 (Figure 3.2A and Supplementary Table 1 (Appendix B)) This is
consistent with the ordering and magnitudes of the reported areas per lipid and transition
temperatures for DOPC 74, POPC75, and POPE 69.
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Figure 3. 2 Area per lipid calculations of the 100-member lipid bilayer for the DOPC, POPC and
POPE and relative helical propensity for Nt17 peptide in the presence of these lipid vesicles.
A) Theoretical area per lipid calculations of the 100-member lipid bilayer for the DOPC, POPC
and POPE. The linear relationship shows that the average area per lipid number for each
DOPC, POPC, and POPE are 68.59, 65.12, 57.26 respectively. B) the relative degree of peptide
helicity as a function of simulation time for all three lipid systems. Here the initial structure for
the Nt17 peptide was completely random coil. Reproduced with permission from the Journal of
Mass Spectrometry: Investigating the interactions of the first 17 amino acid residues of
Huntingtin with lipid vesicles using mass spectrometry and molecular dynamics. Kiani Karanji,
A., Beasley, M., Sharif, D., Ranjbaran A., Legleiter, J. and Valentine, S. J. Journal of Mass
Spectrometry 55 (1), e4470. Copyright © 2019 John Wiley & Sons, Ltd.
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One measurement that provides some insight into interaction differences with the
random coil peptide is the degree of helicity within the peptide as a function of MD trajectory
time.

Figure 3.2B shows the results for the three different lipid systems.

Of note is the

increased degree of helicity achieved for the peptide in the DOPC system simulation. There are
two major times in which extensive helix formation is observed occurring at ~100 and ~470 ns.
It is instructive to observe how helix formation proceeds near these time points. Figure 3.3
shows this for the first time point region.

In both instances, the Nt17 peptide is observed to

interact with the membrane via the first 2 to 3 amino acid residues. Over the next few ns in the
simulation, a single turn to two helical turns is observed. This rapidly propagates to extensive
helical formation (~50% in both cases) with concomitant detachment from the membrane
surface. Notably, the degree of helix formation for the POPC and POPE lipid systems does not
occur to the degree observed in the two instances for DOPC.
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Figure 3. 3 Schematic representations of random coil Nt17 peptide interacting with the DOPC
bilayer.
A) The Nt17 peptide in solution having no contact with the bilayer. B) The peptide interacting
with the bilayer surface after 93 ns simulation time. C) DOPC bilayer inducing some peptide
helical formation. D) The Nt17 peptide leaves the bilayer surface with ~65% helicity at a time of
120 ns. The peptides and DOPC lipid bilayer are shown with the “new cartoon” and “surf”
drawing models, respectively. Reproduced with permission from the Journal of Mass
Spectrometry: Investigating the interactions of the first 17 amino acid residues of Huntingtin with
lipid vesicles using mass spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M.,
Sharif, D., Ranjbaran A., Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1),
e4470. Copyright © 2019 John Wiley & Sons, Ltd.
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Molecular dynamics (MD) simulations: helix-membrane compatibility. Although the
simulations described above present an intriguing possibility regarding differences in helix
initiation roles by different membrane types, it is possible that they do not fully represent the
interactions expected for a system in which the peptide has been incubated extensively in the
presence of the lipid vesicles. Because experimental evidence suggests that, at the membrane
surface, the peptide is helical, MD simulations have also been performed in which the fully
helical peptide is placed at the membrane surface. This was performed as the computational
time required to observe full helix formation while at the membrane surface may be prohibitively
long according to the random coil simulations.
For the helix-membrane studies, the peptide was placed equidistant (29 Å – center of
the bilayer to peptide center of mass) above the three different lipid bilayer head groups. Figure
3.4A shows a heat map representing the distance between each residue in the peptide and the
center of the lipid bilayer across the simulation time. For the peptide-DOPC system, the MD
simulations suggest that the N-terminus section of the peptide helps to maintain the entire
peptide at the surface of the bilayer. This occurs during the first 50 nanoseconds of the
simulation. The process initiates with the N-terminal residues over this relatively short timescale.
Specifically, the first three amino acid residues (M1, A2, and T3), are the first to locate closer to
the lipid membrane (Figure 3.4A).
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Figure 3. 4 Heat maps showing the distance between α-carbons of each residue on the
Nt17 peptide to the center of the bilayer as a function of MD simulation time.
Panels A, B and B show the results for the DOPC, POPC and the POPE bilayer systems,
respectively.

The legend in the figure shows the distance (Å) represented by each color.

Reproduced with permission from the Journal of Mass Spectrometry: Investigating the
interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A.,
Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019
John Wiley & Sons, Ltd.

This is followed by positioning successive residues (moving toward the C-terminus)
within increased proximity of the lipid membrane. Notably, the first three residues are not
associated with the helical character of the peptide obtained from the protein databank. Figure
3.4A also provides information regarding the relative orientation of the peptide with respect to
the DOPC lipid membrane. After 50 nanoseconds, distinct bands are observed in the heat map.
This reveals increased proximity for specific regions of the peptide. For example, residues 1
through 4, 7 and 8, 10 and 11, and 14 and 15 are in much closer proximity to the lipid
membrane. This result is consistent with the suggested structure and topology of the Nt17
peptide interacting with a lipid membrane from solid-state NMR (ssNMR) experiments
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.

The MD simulations for the POPC lipid system (Figure 3.4B) show different behavior
compared with the DOPC results. One similarity is that initial interaction at the N-terminus is
observed for residues 1 and 2 after 50 ns. This, however, is shorter lived for the POPC system
as it disappears after 50 ns. By 150 ns this initial interaction is replaced by primary interaction
at residues 7 and 8 which persists for the remainder of the simulation.

In a sense, this

interaction anchors, to some degree, the peptide and allows other interactions to eventually
occur.

For example, the interaction for residue 1 and 2 is re-established at ~220 ns.

Subsequent interactions for residues 3 and 4, 11, and 14 and 15 are established by ~330, 460,
66

and 490 ns, respectively. The end result is the similar observance of bands associated with
hydrophobic residues showing increased interaction; however, this association occurs at a
much longer time point than that for the DOPC system.
The MD simulations for the POPE lipid membrane reveal a markedly different behavior
regarding peptide-lipid interaction as shown in Figure 3.4C. As noted by the heat map, very little
of the peptide is ever located within 20 Å of the lipid membrane. As with the DOPC model, the
first three residues are located closest to the lipid membrane across the simulation time frame.
Indeed, periodically, the M1 residue is the only residue that locates within 20 Å of the lipid
membrane. Similar to the DOPC system, specific bands in the heat map (Figure 3.4C) reveal
peptide residues exhibiting relatively increased proximity to the POPE lipid membrane; residues
1 and 2, 5 and 6, 9 and 10, 12 and 13, and 16 and 17 are clearly located in increased proximity
to the membrane across the simulation timescale. The clear differences between the modeled
membrane systems are: 1) the residue numbers that are in the closest proximity; and, 2) the
relative degree of proximity (observed to be much greater for the DOPC modeling).

Molecular Dynamics (MD) Simulations: peptide orientation. It is instructive to
consider the origin of the bands presented in the heat maps in Figure 3.4. Notably, for all
systems, the positioning of residues in closer proximity to the lipid membrane is ~3 to 4 residues
apart. This distance in peptide primary sequence suggests a connection to helical structure.
Additionally, the fact that different residues interact with the different lipid membranes suggests
membrane-guided lipid orienting.
Because the Nt17 region is known to form an amphipathic helix
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, it is instructive to

examine the characteristics of the amino acid residues exhibiting greater lipid interaction. Figure
3.5A represents the nature of the peptide-lipid interaction for the DOPC system.

Notably,

because the same residues are involved for the POPC system (Figure 3.4), only the DOPC
system is discussed here. As indicated by the heat map (Figure 3.4A), the peptide is noticeably
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close to the center of the bilayer. This can be observed pictorially in Figure 3.5A where the Nt17
peptide is located exactly at the membrane surface. At this moment in the simulation, the A2,
L4, L7, F11 and L14 residues exhibit the greatest interaction with DOPC lipid molecules which
matches with results from the previously performed ssNMR study
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. Indeed, the general

interaction is between these hydrophobic residues and the lipid tails (Figure 3.5C). These
interactions necessarily cause the more hydrophilic residues of the amphipathic helix to extend
into the aqueous environment. This result is in very good agreement with previous simulations
using this lipid system 34.
Figure 3.5B shows that the Nt17 peptide interacts more distantly with the POPE
membrane surface. Figure 3.5C presents the interaction type between the peptide and one
POPE lipid. This shows a simulation frame in which the peptide is located near its closest
overall proximity to the lipid bilayer. Notably, the protonated K9 and K15 residues are shown to
interact with the zwitterionic head groups. Indeed, the residues that exhibit the closest proximity
to the lipid membrane across the dynamics run (Figure 3.4C) are the hydrophilic K6, K9, S13,
and S16 residues. It is noted that the S16 residue resides next to the protonated K15 residue.
Overall, the peptide-lipid interactions are dominated by hydrophilic residues for the POPE
system.
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Figure 3. 5 Molecular representations of the position/orientation of the Nt17 peptide on the
surface of the DOPC lipid bilayer, and the POPE lipid bilayer.
(A) the DOPC lipid bilayer, and (B) the POPE lipid bilayer. The peptides are shown with the
ribbon rendering of the polypeptide backbone. Hydrophobic residues interacting with the DOPC
lipids are rendered with the “licorice” drawing method and hydrophilic residues are represented
by the “CPK” model. The lipid bilayer is depicted as an electron cloud rendering and the lipid
head groups are emphasized. Panels A and B show results for the MD simulations for the
DOPC and POPE lipid systems, respectively. Note that the DOPC system requires visualization
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from a top-down perspective because a side-on visualization does not reveal the peptide which
is essentially interspersed within the lipid head groups. Schematic representations of the Nt17
peptide interacting with lipid molecules of the DOPC and POPE lipid systems are provided in
panels C and D, respectively. The peptides are shown with the ribbon rendering of the
polypeptide backbone. Hydrophobic residues interacting with the DOPC lipids are rendered
with the “licorice” drawing method and hydrophilic residues are represented by the “CPK”
model. Interacting residues are labeled. A distance measurement is used to represent a
hydrogen bond in the POPE system. Reproduced with permission from the Journal of Mass
Spectrometry: Investigating the interactions of the first 17 amino acid residues of Huntingtin with
lipid vesicles using mass spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M.,
Sharif, D., Ranjbaran A., Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1),
e4470. Copyright © 2019 John Wiley & Sons, Ltd.

A question that arises is what is the net effect of the interactions described above on
overall peptide orientation at the lipid membrane? Figure 3.5 helps to illustrate the net effect of
these interactions. Overall, for the DOPC lipid system, the insertion of the hydrophobic residues
to some degree anchors the peptide right at the lipid surface (i.e., among the head groups) as
shown in Figure 3.5A. Therefore, there is greater disruption of the lipid bilayer at this location.
Conversely, for the POPE system, the peptide is maintained at a distance from the lipid bilayer
surface due to hydrogen bond interactions between charged residues and the head group
constituents (Figure 3.5B). Therefore, the anchoring of the peptide occurs at several Å distance
from the bilayer surface and the membrane integrity is largely preserved. It is important to note
that the relative peptide orientation derived from the MD simulations (Figures 3.4 and 3.5)
strongly supports the mass spectral data (Figure 3.1 and Table 3.1) discussed above. That is,
the increased interaction with a greater number of lipid molecules for the DOPC system would
suggest the observance of a greater number of lipid adducts
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as is observed in the mass

spectra. Furthermore, the greater difficulty to establish the strongly adsorbed peptide for the
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POPC system (Figure 3.4B) could indicate the intermediate number of lipid adducts associated
with this peptide-lipid system.

MD simulations: potential origin of interaction differences. Because the DOPC and
the POPE lipids both contain zwitterionic head groups, it is instructive to consider differences
that could account for the different predominant interactions observed with the MD simulations.
One possibility is that the higher order of the POPE lipid bilayer disallows the interactions by the
hydrophobic residues as are observed for the DOPC system. Here it is proposed that the POPE
lipids can make strong intermolecular H-bonds between the phosphate group on one lipid and
the carbonyl oxygen atom of an adjacent lipid resulting in a higher ordering of the POPE bilayer.
In contrast, the terminal methyl groups of the DOPC system disrupt such hydrogen bonding
networks
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and, therefore, the head group spacing increases. As mentioned above, studies

have hypothesized that the interaction between amphipathic α-helices and membranes are
influenced by short-lived defects created by membrane dynamics

67-68, 79

. Thus, when a

membrane is more fluid there will be more defects, and the peptide will have more opportunity
to explore those defects leading to increased interactions with the lipid tails. Additionally, greater
spacing between the headgroups resulting from membrane curvature may also lead to a higher
propensity of peptide binding.

30

. Based on these hypotheses, it is instructive to compare the

results with the average area per lipid calculations (Figure 3.2A). This analysis shows increasing
numbers of lipidated species with increasing area per lipid.

This supports the idea that the

higher area per lipid value for the DOPC bilayer system could also provide more short-lived
defects for the peptide interaction. The greater disorder (spacing) as well as the more fluid
characteristics of the DOPC system would thus allow for increased interaction between the lipid
tails and the hydrophobic residues as observed in Figure 3.5C.

MD simulations: peptide helical persistence. As mentioned above, the formation of
an amphipathic α-helix is hallmark of the Nt17 tract
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in htt. Notably, it has previously been
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proposed that lipid interactions with the Nt17 amphipathic helix could occur precisely as
suggested by the DOPC MD simulations. It has also been proposed that helix-helix interactions
are required to form early-stage oligomers that ultimately lead to protein aggregation associated
with HD 81. It has also been suggested that peptide-lipid interaction could ultimately induce helix
formation

85

. Therefore, it could be argued that suitable peptide-lipid interactions could favor the

persistence of the amphipathic helix. The time-dependent helical character of the modeled Nt17
peptide has been assessed for the DOPC and POPE lipid systems investigated here. Figure S4
in the Supporting Information section (Appendix B) shows the helical content of the Nt17 peptide
across the two different simulations. For the DOPC simulations, the peptide begins as relatively
helical (~65%). The helicity is almost immediately disrupted within the first few nanoseconds
and is reestablished at the 68% level for the first 70 ns before stabilizing at ~75% for the
remainder of the simulation. The initial collapse and the lower helicity correlate with the initial
interaction of the N-terminal region with the lipid bilayer (Figure 3.3A). The relatively stable
region (sustained helicity) corresponds with increased interaction with the lipid. In comparison,
for the POPE system, no initial collapse is evident, however, a greater number of collapse
events is observed across the entire simulation. Additionally, the overall average level of helicity
trends downward across the simulation and is ultimately observed to be well below that for the
DOPC simulation. These observations are the same for the replicate analysis.

Conclusions
Electrospray ionization - mass spectrometry (ESI-MS) and molecular dynamics (MD)
simulations have been used to study the lipid interaction properties of the first 17 amino acid
residues of Huntingtin protein (htt). In this study, phosphatidylcholine (PC), the most common
lipid in the eukaryotic membrane, as well as phosphatidylethanolamine (PE) lipids were used.
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From mass spectra data, a noticeable difference was observed in the number and type
of peptide-lipid complex ions. The MS spectra indicate that the Nt17 peptide yields more
adducts with the DOPC lipid in both monomeric and multimeric ion forms in comparison to the
POPC and POPE lipids. MD simulations provide atomic insight into these interactions. The
simulation showed that the residues of the Nt17 peptide were generally closer to the center of
the DOPC bilayer throughout the simulation. The amphipathic peptide interacts with the DOPC
bilayer with hydrophobic residues. However, when the POPE lipid bilayer was examined, the
hydrophilic residues interact with the lipid headgroups. Further analysis utilizing the simulation
data reveals that the area per lipid may play an important role in the Nt17-lipid interactions. The
increased surface area for the DOPC bilayer results in a longer lasting interaction as the Nt17
peptide is imbedded within the lipid headgroups resulting in more effective interaction with the
hydrophobic tails. The simulation also suggests that the increased interaction between the Nt17
peptide and the DOPC lipid bilayer leads to greater stabilization of helicity for the peptide.
Conversely, as the peptide increases aqueous interactions as opposed to the lipid bilayer, it
loses some helical character over time. As the Nt17 peptide is a lipid-binding domain, its
interactions with the membrane can lead to the formation of helix bundles at the bilayer surface.
Understanding the nature of these interactions is vital because they can trigger the aggregation
process and ultimately result in disease.
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4. Molecular dynamics simulations of Proteorhodopsin
oligomers in lipid bilayer and micellar systems

Introduction
Proteorhodopsins (PRs) are microbial membrane proteins which exist as an oligomer (usually
pentamer or hexamer) in their native form 1. PRs are found in bacteria and they function as a
proton pump . The ion pumping triggers with a photon absorbed by retinal and a series of
events drive the proton to the outside of the bacteria Figure 4.1) 2. The process starts with the
retinol conformational change from all-trans isomer to 13-cis upon the photon absorption. This
causes the formation of a photointermediate stat for the protein which is known as the K state.
In the next step of the photocycle, D97 receives the proton from the protonated Schiff base
(PSB), resulting in the formation of M state (Figure 4.1 and Figure 4.2). The PSB linkage is a
result of the covalent binding between retinol and a lysine amino acid. A proton istransferred
from the proton-donor E108 to the deprotonated SB, this step forms the N state. The proton lost
by E108 is replaced by a proton from solvent. This state is known as the O state (Figure 4.1) 3.
As H75 has a hydrogen bond with the D97, this interaction tunes the pKa value for the proton
acceptor 4.
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Figure 4. 1 Proteorhodopsin photocycle.
The photocycle starts with isomerization of the retinal molecule from all trans to 13-cis upon the
absorption of a photon. The result of this photocycle is the transfer of a proton from the
bacteria’s cytoplasm to the periplasm.

PRs can be classified as green proteorhodopsin (GPR)

5

or blue proteorhodopsin (BPR)

according to the maximum light absorption 6. PRs can form oligomeric states in order to
increase the protein stability
forms of the protein

9-11

3-4, 7-8

. This oligomerization includes pentameric and hexametric

(Figure 4.2). In the pentameric form, protein monomers such E50-R51

and D52-R51 salt bridges are specifically important for the protein stabilization

7

. In the

hexameric form the corresponding residues in the BPR are E32-R33-S34-D35 in PDB 4JQ6.
Maciejko, J. et al. have suggested that the presence of S34 will result in some degree of
disruption in the R33-D35 salt bridge in the hexameric form therefore the pentameric oligomer is
81

more favorable for the BPR 7. The stability of a proteorhodopsin is also influenced by the
membrane composition

8, 12

. For example, the surface charge effect of the lipid bilayer on the

recruitment as well as the orientation of PR in a detergent-mediated reconstitution procedure
has been investigated by Noy and co-workers

12

. The effect of membrane system on the stability

of oligomeric states of PR is also a subject of debate. It has been possible to capture the
oligomeric PR within DDM 10, and DPC 8 micelles as well as various lipid bilayer systems 7, 138.

Figure 4. 2 Pentameric form of Proteorhodopsin.
The monomers are labeled as A, B, C, D and E. The direction of the proton migration from
cytoplasm to periplasm is shown with a red arrow. The proton donor (E108), retinal, proton
acceptor (D97), and protein releaser (E142) residues are assigned only for the monomer A of
the pentamer. The monomer A is made transparent for better representation of the residues.

Our fundamental understanding of PR’s structure and function is still not complete. The
remaining questions include:
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1. How are the dynamic interactions between the monomers of an oligomeric PR?
2. What is the relation between the structural changes induced by variation of membrane
environments on the PR interactions?
Molecular dynamics (MD) simulations can provide an atomistic insight into these events to
reveal the details of the membrane composition effect on the photocycle as well as structural
stability of PR.
Here we used Gaussian accelerated molecular dynamics (GaMD)

14-15

simulations to investigate

the effect of three detergent systems, n-dodecylphosphocholine (DPC), 1,2-dihexanoyl-snglycero-3-phosphocholine (DHPC), and n-dodecyl-β-D-maltoside (DDM) as well as a bilayer
system 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE): 1-palmitoyl-2-oleoylsn-glycero-3-phosphoglycerol (POPG) on the structure of PR in its oligomeric forms. Detergents
and lipids can be classified as harsh and mild according to their ability to denature proteins

16-17

.

In general, charged detergents with smaller head groups and shorter tails are classified as
harsher detergents

18

. The important residues for oligomerization have also been monitored to

study the oligomeric stability of PR.

Computational Methods
For the starting structure, the X-ray crystal structure of BPR from HOT75 and Med12 in the dark
state (PDB 4KLY and 4JQ6)

4

were used. Missing loops were modeled using MODELLER

based on the NMR structure of GPR (PDB 2L6X)

19

20

. The protonation states of the important

residues in the dark sates are as follows: D97 deprotonated, E108 protonated, E142 protonated,
H75 neutral with HSE protonated, all other titratable residues were in conventional protonation
states.

83

Details of the simulations can be found in Table 1. The CHARMM-GUI server (www.charmmgui.org) was used to create surfactant corona and lipid bilayer system around the protein

21

. In

all cases we make sure that all the hydrophobic area of the protein is covered by
detergents/lipid bilayer. The ionic strength of 100 mM NaCl was used in all the simulations.
All the systems were minimized for 1 ps, then heated up through 4 steps for 0.5 ns with 10
kcal/mol constraints on the protein backbone. The minimization and heating were done with
NAMD 2.13

22

using CHARMM c36 force field for detergents/lipids and proteins

23

. After

minimization, all the simulations were subjected to conventional molecular dynamics (cMD)
simulation followed by Gaussian accelerated MD simulations implemented in NAMD

15

with

GPU acceleration and 2 fs time step. GaMD is a method that applies harmonic boost potential
to enhance sampling by lowering the energy barriers in the 3D energy landscape of a
biomolecule

14-15, 24

. In GaMD there is no need to predefine collective variables (CVs) thus

unconstrained enhanced sampling is achievable

25

. Smoothing the potential energy allows the

MD simulation to cover the processing time of a biological system much faster. For example, a
few hundred of nanosecond of a MD has been suggested to cover the biological processes that
are in the millisecond time scale for membrane protein simulations

14, 26-28

.

For the GaMD simulations, a dual boost potential was applied, to both the total potential energy
and the dihedral terms. NPT ensemble was used for all the cMD and GaMD simulations at 310
K and 1 bar using a Langevin thermostat and a Berendsen barostat. Particle mesh Ewald (PME)
summation was used to calculate the electrostatic interactions

29

. For non-bonded interactions,

a force switching of 10 Å and a cutoff of 12 Å were utilized. Visual Molecular Dynamics (VMD)

22

and LOOS 30 were used to visualize and analyze the data.
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Table 4. 1 Simulation method and run times for all membrane systems.
lipid
#
Membrane

Oligomer

# atoms

(detergent)

Waters / lipid

cMD

GaMD

Total

per

(detergent)

(ns)

(ns)

(ns)

detergents
or lipids
monomer

DPC

DDM

DHPC

POPE:POPG

P

191917

380

76

50141/380=132

77

320

397

P

191917

380

76

132

99

328

429

H

326958

380

63

94050/380=247

445

403

848

H

326958

380

63

247

140

342

482

P

209823

350

70

54381/350=155

54

320

374

P

209823

350

70

155

57

346

403

H

357141

400

66

101029/400=252

253

527

780

H

357141

400

66

252

362

306

668

P

196881

350

70

50655/350=144.7

52

345

397

P

196881

350

70

144.7

83

345

428

H

341878

380

63

97120/380=255

414

308

722

H

341878

380

63

255

84

313

397

P

244212

827

165

40644/827=49

53

311

364

P

244212

827

165

49

52

323

375

D52A-P

244202

827

165

49

37

117

154

R51A-P

244142

827

165

49

37

117

154

H

289929

808

134

55613/808=69

353

1165

1518

H

289929

808

134

69

314

1019

1333

D52A-H

289905

808

134

69

33

102

135

R51A-H

289833

808

134

69

33

103

136

For the simplicity, H and P were used as hexamer and pentamer respectively. Since each
system were simulated in two copies, we were labeling them by 1 and 2. In many cases terms
like LB-H1 were used which means the lipid bilayer-hexamer system and copy 1 was the
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subject. As another example DDM-P2 means the environment is DDM, the protein is in
pentameric form and the copy 2 was discussed.

Results and Discussion
Stability of PR oligomeric complexes. intra-protein contacts often lead to a more
stable protein 31. In the case of PR, it is suggested that forming oligomeric structure is intrinsic
because the protein reconstitutes in different membrane environments

32

33-34

. Protein packing is

also been suggested as another mechanism by which proteins gain stability

35-38

. For example,

Fleming and co-workers showed that membrane proteins have higher packing values than
soluble protein, indicating the helix-packing is an important factor for the stability of membrane
proteins

38

. This packing is mainly due to the transmembrane (TM) helix–helix interfaces. This

tool could be used to measure the efficiency of packing between monomers in an oligomeric
complex. In the present work, the pentameric and hexameric forms of PR were used in different
membrane environments (lipid bilayer, DDM, DHPC and DPC) in the dark sate. To investigate
the oligomeric state stability of PR in different membrane systems, the packing score

39

analysis

was performed. The hypothesis is that denser TM bundle enabling PR to proceed more
efficiently through photocycle. This can be explained by assuming that a closer interaction
between the key residues helps the photocycle to perform faster by stabilizing the protein more
efficiently. Figure 4.3 shows the packing score probability of hexameric and pentameric forms of
PR scaled according to the environment composition. This figure shows that the protein is
generally stable in the timeframe and all the environments that this study was performed in.
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Figure 4. 3 Packing score as measured for all oligomeric systems.
LB = lipid bilayer; DDM = dodecyl maltoside; DHPC: diC7-PC; DPC: dodecylphosphocholine.
H=Hexamer and P=Pentamer. The number 1 and 2 after each system represents the two copy
runs for each system. A-B = monomer A – monomer B, B-C = monomer B – monomer C, C-D =
monomer C – monomer D, D-E = monomer D – monomer E, E-F = monomer E – monomer F,
F-A = monomer F – monomer A. Worth to mention that in the pentameric system the magenta
color is for E-A = monomer E – monomer A. The is no F-A interface in the pentameric systems.

However, hexameric form of the protein in the lipid bilayer is the only system that has 2
symmetric less-packed interfaces in both the copy runs. In LB-H1 system, the interfaces
between C-D and F-A monomers are less packed in comparison to the other four interfaces. For
LB-H2, there are a relatively less packing at the interfaces between B-C and E-F monomers. It
can be inferred that according to the simulation data in the case of the dissociation of the
hexameric system, there will be 2 trimer oligomers in the lipid bilayer environment. For the PRDHPC system, the pentameric form of the protein tend to be more uniformly grouped than
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hexamers. Nevertheless, the hexameric form have higher (more efficient) packing in the PRDPC system.
To further analyze the oligomeric tightness of PR protein, the distance between the center of
masses of the adjacent heptameric TM bundles was measured. Figure 4.4 shows that there is a
clear increase in the average distance (about 2-4 Å) from hexameric to pentameric oligomer of
PR. These results suggest that overall hexameric system pack more tightly than pentamers.
This in general tracks the trends of the packing scores. Notably, for the lipid bilayer systems, the
less packed interfaces have longer center of mass distances (C-D and F-A interfaces in LB-H1
and B-C and E-F interfaces in LB-H2). In another example, the F-A interface in the DDM-H2
system has the lowest packing score, that appears to have the longest center of mass distance.
The same pattern can be applied for the D-E interfaces in DDM-P2 and DPC-P2 systems. It is
essential to mention that the center of mass distance is not necessarily equivalent to the
packing score. While the distance shows how far the center of masses are, the packing score
reflects the short-distance interfaces (such as salt bridges) which by definition of packing score
is a sum over a very short-ranged function ( ). As it is suggested by Glaubitz et al. 7 the beltlike
salt-bridges (D52-R51 and E50-R51), that are located at the top part of the cytoplasmicinteracting site of PR, stabilize the oligomeric forms of PR. While the packing score analysis
reflects the short distance interactions the movements of the rest of the protein causes the
center of mass distances different from the packing score plots.
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Figure 4. 4 Monomer-monomer distances between helix bundles: lipid bilayer vs. detergents.

Cross protomer interactions. As mentioned before E50-R51-D52 salt bridges play an
important role in the oligomerization and stability of PR oligomers. It has been suggested that
breaking the E50-R51 salt-bridge causes a “monomer switch”

7

for PR. Figure 4.5 shows the

distance probability of the interaction at this interface. The distance distribution is generally
more stable for the hexamer than pentamer in all the four studied systems. The salt bridge
distance is ~4 Å, however, in some cases the salt bridge is broken and the distribution shifts to
6-7 Å. For instance, the interface between monomer E and F and B-C in LB-H2 system is
broken at some point. The probability of breaking this interaction is also noticeable in some
pentamer systems such as in DDM-P and DPC-P.

89

Figure 4. 5 Salt bridge distances between E50-R51.

Another important salt bridge is between D52 and R51. Figure 4.6 shows the distribution of this
interaction for the PR protein in different environments. Compared to the E50-R51 salt bridge,
D52-R51 interaction is more stable. Except for the LB-H system in which there is a notable
higher distance for the other systems only a small tail was observed. Furthermore, a shorter
distance between the D52-R51 than E50-R51 was observed especially for the pentameric
systems.
Generally, it is essential to know which salt bridge is stronger in the PR to control the monomeroligomer population. A desired population of monomer can be obtained by mutating the correct
residue in a pentameric or hexameric systems in different environments. This work can guide
through new mutations in order to control the monomer-oligomer populations.
It worth mentioning that the salt bridges are fundamentally different in hexamer and pentamer
forms of PR. While in the pentameric system form the sequence is regular E50-R51-D52, in the
hexameric form there is an additional residue (serine) between R51 and D52 which affects the
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stability of the salt bridge triad in the hexamer. This is most likely why there is a longer distance
between D52-R51 in hexamer compare to the same distance in pentamer.
Also, a 2D plot relation between the R51 χ1 dihedral angle and D52-R51 and E50-R51
distances shows that weaker packing from detergent environments allows E50-R51-D52 to
interact more closely, specifically in that +/- 60-degree orientation. As such, DHPC systems are
the only ones that noticeably sample R51 dihedral angle at +/- 60 that are combined with short
enough distance to form a salt bridge. In comparison to hexameric system in DHPC (Figure
S4.3 (Appendix C)), the pentameric system in DHPC (Figure S4.4 (Appendix C)) demonstrate a
definite shift in the population of the R51 dihedral which causes this system to have much larger
percentages of simulation time in +/- 60 deg orientation, coupled with tighter binding to
E50/D52. Part of this is attributable to the additional residue in the hexamer system (as
mentioned before). In this case, membrane environment is not as important, rather the
oligomeric form and the position of salt bridge triad is critical. (compare Figure S4.3 (Appendix
C) and Figure S4. 4 (Appendix C)).
To further investigate the effect of E50-R51-D52 salt-bridges on the protein packing score the
mutation of D52 and R51 to alanine were performed separately for both the oligomer systems in
the lipid bilayer environment. Figure S4. 1 (Appendix C) represents the packing score analysis
for the wildtype PR in the lipid bilayer system versus mutated version of the protein in the same
environment. The analysis reveals that the mutation of either D52 or R51 leads to weaker
oligomeric bundle packing. This is more pronounced weakening of the interface for R51A. The
center of mass analysis shows that the mutations lead to slight increase in hexamers but have
no effect or decrease in pentameric systems (Figure S4. 2 (Appendix C)).
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Figure 4. 6 Salt bridge distances between D52-R51.

Other than the two well known cross protomer interactions in the PR oligomers, the salt bridge
between D52 and K59 at the ajdacent monomers are also important. Figure 4.7 depicts a strong
indications between D52-K59 salt bridge. This interaction is more of a factor in stabilization of
the hexamer vs. pentamer, regardless of membrane environment. In all lipid bilayer and
detergent enviromets a close interaction between D52-K59 is centered around <4 Å for
hexameric systems that is much more stable than the same interaction for the pentameric
systems in which the distrubution is more expanded. In most of the cases in the pentamer
systems there is at least one interface that are close to each aother (have a distance <4 Å) but
this not consitent for the other interfaces. For example the interface between monomers D-E in
DDM-P, DHPC-P, and DPC-P is close but the other interfaces are not as close as the interface
between D and E.
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Figure 4. 7 Salt bridge distances between D52-K59.

W34-H75 interaction. Because of the effect of the H75 on the pKa value of the proton
acceptor D97 investigating the hydrogen bond between W34 and H75 is important

40-41

. The

H75 distance analysis reveals that while there is a distribution of distances from 2.5-7.5 Å,
regardless of the membrane system for H75-D97 interaction (Figure S4. 5 (Appendix C)), the
W34-H75 distance is much more pronounced at extremely short distances at <2.5 Å (Figure 4.
8). Also, for all the studied systems there is a peak that is centered ~4 Å which is still a strong
interaction between W34 and H75. In some cases, in some of the monomers the distance
increases to >5 Å (Figure 4. 6). Furthermore, the χ1 dihedral angle analysis of H75 reveals that
this residue adopts 2 conformations in the pentamer (-60 and 180) versus one conformation in
the hexamer (-60), but not directly related to interactions with either D97 or W34 (Figure S4. 6
(Appendix C) and Figure S4. 7 (Appendix C)). As it is suggested by Luecke and coworkers
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W34D mutation causes a drastic alteration in the BPR function

4

the close interaction of W34

and H75 is playing an important role in the photochemical activity of PR.

Figure 4. 8 Hydrogen bond between W34 and H75.

Retinal binding pocket. One initial step to help with photoisomerization is to transfer a H+
from the protonated schiff base (PSB) on the retinal to the proton acceptor D97. The pKa value
of the PSB is affected by the localized changes in the binding pocket. Two important residues
that the PSB is interacting with are D97 and D227 that according to the x-ray structure of PR the
D227 is in closer interaction with the PSB4.

D227 is important because retinal

photoisomerization selectivity is controlled by this residue42. Also, it is been shown that D227
has a critical role in modulating the pKa value for the PSB and therefore the rate of the
photocycle of proteorhodopsin43. Figure 4. 9 and Figure 4. 10 show that in the hexamer system
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D227 is stabilizing the PSB in the all-trans conformation, while D97 is free to fluctuate. A close
interaction (>4 Å) between the NZ atoms of the D227 with the NZ atom at the retinal in all the
hexamer systems is shown in Figure 4. 9. The same analysis for the distance between D97 and
retinal in Figure 4. 10 shows a broad distribution of probabilities for the D97-retinal distance in
the hexamer systems. This is indicating that only after isomerization the D97 residue is close
enough to the PSB to facilitate proton transfer characteristic of the K to M transition.
Conversely in the pentameric system, D97 is (potentially) bridged with water molecule to PSB,
allowing it to be more stable (Figure 4. 10). In contrast, D227 is more distant, but only for a
subset of monomers (Figure 4. 9).

Figure 4. 9 Retinal binding pocket: Schiff base to D227.
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Figure 4. 10 Retinal binding pocket: Schiff base to D97.

Conclusion
Molecular dynamics simulations were used to study proteorhodopsin protein in its oligomeric
(pentameric and hexameric) form in four different membrane environments. To study the
stability of PR the packing score and salt bridge analysis were performed. The packing score
and center of chain distance analysis showed that the PR is stable in both the pentameric and
hexameric form in all four membrane systems in the simulation time scale. The distance
analysis of important salt bridges also reveals that D52-R51 is especially important in the
pentameric system. Another salt bridge that is obviously strong in the hexameric system and
less pronounce in the pentameric system was the D52-K59 interaction. The W34 interactions
were also studied to investigate the importance of the W34-H75 interaction in the photochemical
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activity of proteorhodopsin. Finally, the interaction between the PSB and close aspartic acid
residues were studied.
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5. Future Directions: protein characterization using mass
spectrometry and molecular dynamics simulations
Determine the solution structure of pHLIP in state I
pHLIP is a negatively-charged, membrane-active peptide which potentially can be used
to deliver drugs to the cellular environment 1. Ongoing research is directed at determining the
structure, interactions, and functional properties of this peptide. Researchers have divided the
functional properties into three states 2: in state one the peptide is in solution and has no
secondary structure; in state 2 the peptide is at the surface of a lipid bilayer and can bind to it
under basic conditions while the structure is still random coil; and, finally, for the state 3, by
changing the pH to slightly acidic conditions which introduces positive charge to the acidic
residues, pHLIP folds into an α-helix and penetrates the bilayer 3. The pHLIP structure in the
solution phase (state I) is not completely understood. Identifying the helical region(s) of the
pHLIP peptide at physiological and low pH is a crucial step to garner a better understanding of
the peptide structure in state I. This could lead to more effective pHLIP targeting for tumor cells
4-6

.
Different analytical tools such as circular dichroism (CD), NMR and fluorescence

spectroscopy as well as other techniques like MD simulations have been utilized to characterize
pHLIP behavior in these states

1, 5, 7-9

. Online, solution hydrogen-deuterium exchange (HDX) can

be used to identify the pHLIP structure when it is not interacting with lipids

10

. This approach can

provide the amount of deuterium incorporation for each residue within the peptide. The amino
acids that are more accessible (less involved in hydrogen bonding) to solution exchange will
experience more deuterium uptake. That is, HDX can reveal the secondary structure of the
peptide in solution at the amino acid residue level. This is accomplished with native MS and
tandem mass spectrometry (MS/MS) employing electron transfer dissociation (ETD)

11-12

.
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Ion mobility spectrometry (IMS) coupled with gas-phase HDX (IMS-HDX) can also be
used to determine the structural properties of the peptide

13-15

. Drift time measurements using

IMS can provide information about the number of unique solution conformations that the peptide
exhibits. By using ion mobility spectrometry- ion mobility spectrometry (IMS-IMS) we can select
a specific conformer in the first IMS and introduce it to the second IMS in order to perform HDX.
Recently, it has been shown that peptide ions in non-helical states have distinguished deuterium
uptake compared to helical states using gas phase IMS and HDX

16

. Thus, a per-residue

analysis such as that proposed here could reveal the location of helical portions of
proteins/peptides. These techniques can be used in conjunction with the solution-phase HDX
and MD simulations to reveal the location of helical turns in the pHLIP peptide as has been
accomplished for model peptides

17-22

.

To confirm the structural changes when the pH is reduced from 7 to 2.5, CD spectra
were recorded for the wild type pHLIP peptide at the different pH values mentioned above. Fig.
5.1 shows that the helical propensity for the peptide increases from ~2% to 10% when the pH is
reduced from 7 to 2.5. Finding the residues that are responsible for this helix formation is
important. HDX coupled with an enzymatic digestion method can also be used to identify the
helix portion

14, 23-24

. Here, the ability of each fragment to uptake deuterium is calculated upon

digestion of the peptide with the enzyme pepsin.
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Figure 5. 1 CD spectrum of pHLIP recorded at two different pH levels.

Figure 5.2 shows the setup that can be used in order to perform online, solution-phase
hydrogen deuterium exchange

10

. In this setup the pHLIP peptide will interact with D2O for a

select period of time based on solvent flow rates and capillary diameters. Subsequently the
analyte solution will undergo online digestion using the enzyme pepsin. The digestion will also
be conducted for a select period of time. The pHLIP:D2O ratio will be set to be 5:95. The flow
rate for the pepsin is typically maintained at the flow rate for the peptide solution. Additionally,
kinetics studies will be performed by changing the length of the reaction capillary and the flow
rates of the solutions. For example, by changing the flow rate for the peptide solution to 2
µL/min (Figure 5.2) and the flow rate for the D2O solution to 38 µL/min, the HDX reaction time
will increase to 10 seconds.
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pHLIP
5 µL min-1

T1

95 µL min-1
D2O

TDHX
0.6 s
L=5.5 cm

T2
MS

5 µL min-1
Pepsin Digestion
and Acid Quench

Figure 5. 2 Online hydrogen deuterium exchange apparatus. The peptide solution and water
mixing occurs at T1 and HDX occurs along L. By changing this length, different exchange rates
can be measured.

Determine the effect of membrane composition on permeation of pHLIP in
membrane
For proteins that insert into the membrane, many contain mostly short peptide sequences that
can penetrate the membrane and transport cargo or disrupt the function of the membrane upon
insertion

25-27

. Studying these species and the method of insertion is important because it may

permit, for example, the selection and optimization of drug delivery peptides based on their
binding energies to the membrane. pH (low) insertion peptide (pHLIP) is a cell-active peptide. It
is known that pHLIP inserts into the lipid bilayer membrane at pH ~ 6.1 while a pH value around
that associated with cancer cells is ~6.8. Therefore, there is a need to develop strategies to
facilitate pHLIP insertion at higher pH values. A larger area per lipid might aid membrane-active
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peptide insertion. Differences in the lipid systems could play a role in the degree and type of
peptide-lipid interactions. Membranes also have a capture and stabilization effect on the
peptide. However, the insertion ability of this peptide requires the presence of both the
membrane and a decreased pH value. The increase in area per lipid might reveal a threshold
size for “turning on” peptide-lipid interaction (and thus insertion). That is, the peptide may be
able to insert at a higher pH just by changing the area per lipid value of the membrane. The
structural details of pHLIP (as a membrane-active peptide) including interactions with different
lipid systems can be examined with native MS and MD simulations. Peptide-lipid bilayer
interactions can be examined at neutral pH to study the effect of membrane composition. To
obtain experimental information about the role of membrane composition on the lipid-binding
ability of pHLIP, the insertion ability as a function of membrane (completely saturated as with
DMPC to high area per lipid such as 4ME 16:0 PC) can be investigated. It is expected that the
peptide will insert more readily into the membrane with larger area per lipid. A better
understanding of the conformational changes of the membrane-active peptide as the lipid
system changes will provide a better understanding of how this peptide functions.
A recent NMR study shows that pHLIP in state II, when it is at the surface of a bilayer,
exhibits an interaction with the POPC headgroups 8. The study was performed at three different
pH values. It was shown that, depending on the pH, there is a distinct difference between the
ability of pHLIP to get absorbed at the lipid surface. It was demonstrated that the peptide
penetrates deeper into the membrane at pH ~6.4. As a membrane with higher area per lipid
value provides more spacing for the peptide to insert, it is interesting to study the interactions
between the peptide with other PC lipids using native MS. Figure 5.3 represents the mass
spectrum for the interaction between pHLIP and POPC lipid vesicle.
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pHLIP-POPC mass spectrum
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Figure 5. 3 The mass spectrum (ESI-MS) for a pHLIP-POPC system. Different monomeric and
multimeric ions are labeled (see legend for details.

As mentioned above, because cancer cells exist in a slightly acidic medium, pHLIP can
differentiate between a cancer cell and healthy cells 2. Therefore, pHLIP insertion into a
membrane thus makes it a good candidate for targeted therapy

28

. That said, initial peptide-lipid

interactions can represent an essential step associated with a variety of membrane-active
peptide functions or they can represent other serious disorders resulting from oligomerization of
a non-penetrating peptide

29-35

. As such, many other physiological conditions are directly related

to initial interactions between the peptide’s residues and the hydrophilic head group or the
hydrophobic tail of the membrane. Providing detailed knowledge of the peptide-lipid membrane
interactions can ultimately result in the development of new treatment strategies for different
diseases.

105

The strange case of leptin; an electrospray ionization study
Ionizing molecules is an obvious prerequisite step for mass spectrometry (MS)
experiments

36

. Due to the softness of the method, the ability of providing multiply-charged ions,

and the ease of coupling with analytical instruments, the most common technique to accomplish
the ionization step in commercial MS devices is electrospray Ionization (ESI)

37

. The importance

of studying the mechanism of the ESI process is in intelligently designing better experiments
using ESI-MS as well as for the construction of improved MS instrumentation. In ESI, a solution
is infused through a needle that is biased relative to the mass spectrometer inlet. The applied
electric field causes a destabilization of the liquid meniscus and the formation of a Tayler cone
36-39

. This generates a stream that will disintegrate into micrometer-sized droplets with excess

charge. These droplets will then undergo a series of solvent evaporation and fission events until
the naked analyte ion is introduced into the mass spectrometer. The process of evaporationfission can happen several times up to a point such that the radius is small enough (<10 nm) for
the molecule to leave the droplet

37

. It is possible to obtain different populations of ions having

different numbers of protons attached and creating characteristic charge state distributions in
the mass spectrum.
For small ions (low molecular weight such as sodium), the proposed mechanism is the
ion evaporation model (IEM)

40-41

. In this mechanism small ions can eject from a droplet in the

final stages of the ESI process. Conversely, for high molecular weight systems such as proteins,
two mechanisms have been proposed including: the charged residue model (CRM)

42-44

and the

chain ejection model (CEM) 36.
Notably, the charge state distribution (CSD) of proteins in the mass spectrum is
significantly different for folded and unfolded proteins which suggests that the ionization process
is different for these two states; CEM is suggested for proteins in their folded state and the CRM
is for unfolded proteins

45

. In CEM hydrophobic and electrostatic forces drive the protein to the
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surface of the droplet and when the protein is expelled from the droplet, some charges at the
surface of the droplet will be transferred to the protein

45

. In CRM, the evaporation continues

until the solvent is completely evaporated and the remaining charge is transferred to the protein
44, 46

. For proteins with a mixture of secondary structure and unstructured regions, the

mechanism might be different. For example, leptin is a globular protein which is responsible for
normalizing body weight
Figure 5.4 (B).

47-49

. A recently acquired ESI-MS spectrum for this protein is shown in

Here the protein was electrosprayed using native MS solvent conditions.

Noticeably the spectrum consists of two regions: one region with low CSD centered at +8 and a
second region with high CSD centered at +11. For comparison purposes, a spectrum for the
globular protein myoglobin conducted under the same conditions as those for the leptin protein
was collected (Figure 5.4). For myoglobin, the overall number of separate charge states is
reduced, and they are centered around +8. In addition, the signal level for the leptin protein was
about an order of magnitude larger than that of myoglobin. Taken together, this indicates that
the ionization method could be very different for leptin; notably, as a compact globular protein,
myoglobin may be expected to follow the traditional CRM process. Such a difference may resul;t
from the unstructured region of the leptin protein which results in the bi-model CSD. Analyzing
the crystal structure of leptin

47

reveals that 35% of the residues comprise random coil regions

which mostly range from Ser25 to Gly38 (14 residues) and Leu39 to Thr 50 (11 residues) and
Ser95 to Leu107 (12 residues). This unstructured region comprises almost an entire face of the
protein. The same analysis for myoglobin

50

shows that only 20% of the residues are in the

random coil regions and the longest stretch of random coil residues ranges from Phe43 to Thr
51 (9 residues).
To further investigate the electrospray ionization behavior of these two proteins we
utilized molecular dynamics (MD) simulations. Most of the mechanistic studies for the last
stages of the ESI process have been performed by MD simulations. Two water droplet systems
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with ~4.5 nm radius and a protein in their center have been initially modeled. The droplet charge
for each system is assigned to be lower than the Rayleigh limit. Figure 5.5 depicts the
movements of each protein within its respective droplet. The MD simulations show that the
leptin protein tends to present near the surface of the droplet while the Myoglobin remains
closer to the droplet center. The snapshots of these movements show that the random coil
regions of the leptin protein play an important role in driving the protein to the droplet surface.
Clearly, repeated studies must be conducted to conclude that such behavior is affected by these
regions and this is not just Brownian motion. Additionally, a longer simulation time is required to
see the ejection of the protein from the droplet. Konermann and co-workers have already shown
that for a completely denatured protein the ejection happens in <10 ns time frame

45

.

A

difference is the overall size of the water droplet. The larger size was selected to better track
the interaction with the droplet surface over time.
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Figure 5. 4 Mass spectra for for A) Myoglobin and B) leptin generated by native MS. Here the
proteins were electrosprayed from buffered (100 mM ammonium acetate) solutions. Charge
states are labeled for each protein. Insets show the structures of the two different proteins.
Note the long, unstructured region for the protein leptin which comprises an entire face of the
protein.
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Figure 5. 5 The distance profile of the center of mass for myoglobin and leptin proteins to the
water droplet center of mass. The distance to the droplet surface is provided. The two different
traces are labeled for the respective proteins.

Modeling the CRM behavior of proteins will require a substantially a longer time

39, 51-52

. Future

studies should be conducted in which the droplet drying is allowed to proceed to the point of ion
ejection or ion formation via CRM.

From multiple analyses, it may be possible to deduce

whether or not it will be possible to form leptin ions via the CEM process. Other experiments
can be conducted in which proteins of varying degrees of unstructured region are examined to
observe whether or not the CEM holds for those of higher unstructured state. To these studies,
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ion mobility spectrometry investigations can be added. For example, with IMS it will be possible
to determine whether or not the protein ions exhibit a greater change in conformational size as
evidenced by comparisons of ion cross sections with those calculated for the native state using
the crystal structure coordinates.

These same experiments can also be conducted for the

similar proteins with long unstructured regions comprised of >30% random coil residues.
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Appendix A
Figure Captions
Figure S2. 1. CD spectroscopy of both model peptides PAAAAKAAAAKAAAAKAAAAK and
PSSSSKSSSSKSSSSKSSSSK. The alanine sequence is showing a high-degree of helical
character as indicated by the negative bands at ~207 and 223 nm as well as the positive band
at ~190 nm. For the serine sequence peptide, the helicity is missing and a broad band at lower
wavelengths is indicative of more random coil character.
Figure S2. 2. Conformational space sampling of 40-ps and 1200-ps SA for each conformer
arrangement. The structures with the collision cross section within ±2% are in red dash line
section.
Figure S2. 3. An example of very compact ion conformer type with charge configuration of
K6_K11_K21 and theoretical CCS value of 348 Å2 Calculated by Mobcal software. This
structure has a significant charge solvation of the charge sites by the serine residues.
Figure S2. 4. Schematic of S4 and S5 is explaining the increase in the predicted deuterium
content for the conformer with high accessibility at the terminal peptide portions rather than the
interior residues. These residues are close to the carbonyl groups showed by stars.
Figure S2. 5. A) One structure with a wrong CCS value but showing a high D incorporation
value for S20. Hydroxyl and amine groups are bending back to the structure while for S18 these
functional groups are facing outside. B) Visualizing the same structure on another view is
showing that S2 is bending inside the structure and S4 is bending outside.

Table Captions
Table S2. 1. Deuterium uptake values calculation for serine residues in the model

peptide.
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Figure S2. 2 Conformational space sampling of 40-ps and 1200-ps SA for each conformer
arrangement.
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Figure S2. 3 An example of very compact ion conformer type with charge configuration of
K6_K11_K21 and theoretical CCS value of 348 Å2 Calculated by Mobcal software.

Figure S2. 4 The increase in the predicted deuterium content for the conformer with high
accessibility at the terminal peptide portions rather than the interior residues.
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Figure S2. 5 An example of a structure with a wrong CCS value but showing a high D
incorporation value for S20.
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Residue Number
S2
S3
S4
S5
S7
S8
S9
S10
S12
S13
S15
S7
S8
S9
S10
S12
S13
S14
S15
S17
S18
S19
S20
S2
S3
S4
S5
S7
S8
S9
S10
S12
S13
S15
S7
S8
S9
S10
S12
S13
S14
S15
S17

Fragments
z19
z18
z17
z16
z14
z13
z12
z11
z9
z8
z6
c7
c8
c9
c10
c12
c13
c14
c15
c17
c18
c19
c20
z19
z18
z17
z16
z14
z13
z12
z11
z9
z8
z6
c7
c8
c9
c10
c12
c13
c14
c15
c17

m/za
1821.88
1734.80
1647.72
1560.64
1345.39
1258.31
1171.23
1084.15
868.90
781.82
607.66
720.76
807.84
894.91
981.99
1197.25
1284.33
1371.40
1458.48
1673.74
1760.82
1847.89
1934.97
1821.88
1734.80
1647.72
1560.64
1345.39
1258.31
1171.23
1084.15
868.90
781.82
607.66
720.76
807.84
894.91
981.99
1197.25
1284.33
1371.40
1458.48
1673.74

m/z D2O
1839.86
1752.52
1665.13
1577.47
1357.91
1270.36
1182.63
1094.79
876.53
788.94
613.65
726.59
814.11
901.83
989.67
1207.91
1295.47
1383.14
1470.92
1689.80
1777.09
1864.65
1952.82
1839.82
1752.50
1665.16
1577.51
1358.06
1270.42
1182.71
1094.84
876.53
789.00
613.62
726.40
813.97
901.62
989.59
1208.01
1295.54
1383.10
1470.88
1689.94

D uptakeb
0.79
0.26
0.31
0.58
0.58
0.47
0.65
0.76
0.55
0.51
0.76
0.75
0.44
0.64
0.76
0.56
0.48
0.59
0.70
0.60
0.21
0.48
1.09
0.95
0.24
0.26
0.57
0.78
0.56
0.63
0.79
0.58
0.45
0.81
0.67
0.49
0.57
0.89
0.67
0.45
0.48
0.70
0.69
120

Residue Number
S18
S19
S20
S2
S3
S4
S5
S7
S8
S9
S10
S12
S13
S15
S7
S9
S10
S13
S14
S15
S17
S18
S19
S20

Fragments
c18
c19
c20
z19
z18
z17
z16
z14
z13
z12
z11
z9
z8
z6
c7
c9
c10
c13
c14
c15
c17
c18
c19
c20

m/za
1760.82
1847.89
1934.97
1821.88
1734.80
1647.72
1560.64
1345.39
1258.31
1171.23
1084.15
868.90
781.82
607.66
720.76
894.91
981.99
1284.33
1371.40
1458.48
1673.74
1760.82
1847.89
1934.97

m/z D2O
1777.26
1864.83
1952.80
1838.79
1751.25
1663.77
1576.02
1356.59
1269.03
1181.28
1093.51
875.23
787.71
612.50
724.95
900.16
987.95
1293.91
1381.42
1469.14
1688.66
1776.17
1863.71
1951.83

D uptakeb
0.24
0.49
0.89
0.82
0.46
0.40
0.67
0.71
0.48
0.67
0.69
0.56
0.44
1.05
0.67
0.58
0.71
0.50
0.43
0.64
0.77
0.43
0.46
1.04

Table S2. 1 Deuterium uptake values calculation for serine residues in the model peptide.
m/za recorded for lipid sequence without D2O
D uptakeb calculated for each residue
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Appendix B
Figure S3. 1. Mass spectrum showing the ions obtained upon ESI of the Nt17-POPC and Nt17POPE vesicle systems (compare with Figure 1 in the manuscript). For labeling purposes, a
large red circle represents a single Nt17 peptide, a green triangle represents a single lipid
molecule. Insets show expanded regions in which specific ions would be present. Notably the
Nt17+7POPC, Nt17+6POPE and Nt17+7POPE ion species are not observed although their
counterparts for the DOPC system are present in relatively high abundance (Table 1 in the
manuscript).

Figure S3. 2. Relative intensities of lipid-bound peptide peaks in mass spectra for Nt17-DOPC
(A) Nt17-POPC (B) and Nt17-POPE (C) systems. In each case [Nt17+2H2+ has been chosen as
the reference for scaling (ratioing) the intensities. Lipids bound to monomer, dimer, trimer and
tetramer are shown in blue, orange, yellow and gray, respectively.

Figure S3. 3. Isolation of [Nt17+1L+2H]2+ ions for DOPC (A) and POPE (B) in the linear ion
trap mass spectrometer. For labeling purposes, a large red circle represents a single Nt17
peptide and a green triangle represents a single lipid molecule.

Figure S3. 4. The relative degree of peptide helicity as a function of simulation time for the
three lipid systems. Here the initial structures for the Nt17 peptide exhibit ~70% helicity.
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Table S1. Structural properties of the modeled lipid membranes.

Lipid bilayer

Area per lipid from
Experiment (Å2)

Calculated average
area per lipid (Å2)

Calculated
Thickness (nm)

Calculated radius
of gyration

DOPC

67.453

68.59 ± 1.02

38.63 ± 0.03

27.42 ± 0.01

POPC

64.354

65.12 ± 1.01

39.03 ± 0.15

26.91 ± 0.03

POPE

56.655

57.26 ± 1.01

42.27 ± 0.45

25.75 ± 0.16

Table S3. 1 Structural properties of the modeled lipid membranes.
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Figure S3. 1 Mass spectrum showing the ions obtained upon ESI of the Nt17-POPC and Nt17POPE vesicle systems.
Reproduced with permission from the Journal of Mass Spectrometry: Investigating the
interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A.,
Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019
John Wiley & Sons, Ltd.
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Figure S3. 2 Relative intensities of lipid-bound peptide peaks in mass spectra for Nt17-lipid
vesicles.
Reproduced with permission from the Journal of Mass Spectrometry: Investigating the
interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A.,
Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019
John Wiley & Sons, Ltd.
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Figure S3. 3 Isolation of [Nt17+1L+2H]2+ ions for DOPC (A) and POPE (B) in the linear ion trap
mass spectrometer.
Reproduced with permission from the Journal of Mass Spectrometry: Investigating the
interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A.,
Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019
John Wiley & Sons, Ltd.
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Figure S3. 4 The relative degree of peptide helicity as a function of simulation time for the three
lipid systems.
Reproduced with permission from the Journal of Mass Spectrometry: Investigating the
interactions of the first 17 amino acid residues of Huntingtin with lipid vesicles using mass
spectrometry and molecular dynamics. Kiani Karanji, A., Beasley, M., Sharif, D., Ranjbaran A.,
Legleiter, J. and Valentine, S. J. Journal of Mass Spectrometry 55 (1), e4470. Copyright © 2019
John Wiley & Sons, Ltd.
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Appendix C

Figure S4. 1 R51 dihedral angle in DHPC-H. A) D52-R51 distance, B) E50-R51 distance.
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Figure S4. 2 R51 dihedral angle in DHPC-P. A) D52-R51 distance, B) E50-R51 distance.
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Figure S4. 3 Packing score for WT vs mutations.

Figure S4. 4 Distance between the center of monomers, WT vs mutations.
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Figure S4. 5 Distance between H75 and D97.
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Figure S4. 6 H75 dihedral angle. A) H75-D97 B) W34-H75 distances in LB-Pentamer system.
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Figure S4. 7 H75 dihedral angle. A) H75-D97 B) W34-H75 distances in LB-Hexamer system.
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